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Abstract 
Laser application in the field of biological and medical sciences has significantly grown, thereby 
strengthening the field of Biophotonics. Research conducted in Biophotonics focuses on the concept 
of using light especially in the visible and near infrared regions of the electromagnetic radiation for 
the evaluation of living systems. In this thesis new discoveries are presented about low level laser 
therapy, optical trapping, transmission spectroscopy, luminescence spectroscopy and structured 
illumination microscopy (SIM), displaying the impact each technique has on HIV infected cells. The 
results showed that the irradiation of HIV-1 infected TZM-bl cells with low power red laser reduces 
HIV-1 infection. The outcomes of this study further proved that when irradiation is used in 
conjunction with efavirenz, an antiretroviral drug, HIV-1 infection could be reduced to undetectable 
levels in TZM-bl cells. Through the coupling of transmission spectroscopy with optical trapping, and 
separately, use of luminescence spectroscopy, label free diagnosis of HIV in infected cell samples 
was achieved. This finding affirms that HIV-1 infection can be detected in a label free manner when 
using laser based techniques. Furthermore, the photoluminescence spectrometer system was 
employed to generate a decay curve, which was necessary so as to have some understanding on 
lifetime of the luminescent signal in infected TZM-bl cells. Finally, in order to confirm that indeed 
TZM-bl cells were infected, an established super-resolution microscopy system SIM was used to 
detect HIV-1 infection in TZM-bl cells. Indeed in the infected cells viral molecules p24 and gp41 
were detected through SIM, while they were not detected in uninfected cells. In future studies, super 
resolution microscopy would be coupled to an optical trapping system in order to confirm that each 
trapped cells is whether infected or uninfected so as to improve HIV diagnosis. 
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Chapter 1 
 
Introduction 
 
1.1 Preface 
The human immunodeficiency virus (HIV) is a retrovirus which belongs to a group of viruses 
known as lentiviruses that cause chronic and fatal diseases identified by long incubation 
periods, in the infected victim [1]. HIV causes acquired immunodeficiency syndrome (AIDS), 
a condition which occurs in humans due to the failure of the immune system thereby permitting 
opportunistic infections to flourish [2]. It is transmitted through sexual contact, exchange of 
bodily fluids such as blood, breast milk, and an infected mother can transmit HIV to the unborn 
child during pregnancy and at childbirth as the child gets exposed to the mother’s blood or 
vaginal fluid [3]. The average survival time for infected individuals without treatment is 
estimated to 11 years depending on the HIV type, as HIV has two main types; HIV-1 and HIV-
2, with HIV-1 being the most prevalent and the cause of the epidemic [4]. HIV-1 has three 
distinct groups, which are M, O and N; that have been differentiated based on variations in the 
envelope (env) region. Group M constitutes approximately 90% of HIV-1 infections and is 
subdivided into subtypes A, B, C, D, F, G, H, I, J, K and circulating recombinant forms (CRFs). 
With HIV-1 subtype C being the most prevalent in the Sub-Saharan Africa [5].  
 
Despite extensive research that has been conducted in finding a cure for HIV infection, none 
has become available, therefore it remains a major global health problem and more than 35 
million people have died from the infection since the start of the epidemic [6].  
2 
 
According to the UNAIDS latest fact sheet, by the end of 2018 there were approximately 37.4 
million people living with HIV and more than 1.8 million became newly infected in 2018 [6].  
 
As per the World Health Organization (WHO) reports, the African continent is the worst 
stricken region in the globe, with approximately 25.7 million infected people as it can be seen 
in Figure 1.1, and this accounts for almost two thirds of global HIV infections [7].  
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Figure 1.1 The global HIV infection estimates by the World Health Organization showing the estimated number 
of infected individuals per region [7]. 
 
Of note, South Africa has the largest HIV epidemic in the world, with 7.7 million infected 
individuals, which constitutes 20.4% of the general South African population [9]. In addition, 
approximately 240,000 new infections and 71,000 AIDS related deaths were reported at the 
end of 2018 [8]. Even though there is no cure for HIV infection yet, great strides have been 
made to dampen the detrimental effects of the infection by using antiretroviral (ARV) drugs.  
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Universally, the use of HIV treatment has improved over the years. Figure 1.2 shows that in 
2000 only 0.6 million people had access to treatment, but that number had doubled by the end 
of 2018 to 23.3 million [9].  
 
 
Figure 1.2 Persons living with HIV on antiretroviral treatment around the globe from 2000 to 2018 [9]. 
 
The ARV drugs control the infection and prevent transmission so that the infected individuals 
can have long and productive lives. In South Africa, its effectiveness is further demonstrated 
by an increase in national life expectancy from 61.2 to 67.7 years. Moreover, lately 3.9 million 
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HIV infected people are on treatment and that is a significant improvement compared with just 
over 600,000 individuals that were reported to be on treatment in 2009 (Figure 1.3) [10]. 
 
 
Figure 1.3 The increase in the number of people receiving antiretroviral treatment in South Africa from 2009 to 
2016 [10]. 
 
These numbers continue to grow after the introduction of the universal test and treat strategy 
in September 2016 [10]. Since the challenge with HIV-1 is far from over, investigations 
towards laser based treatment and detection of HIV-1 were pursued and presented for the first 
time in this thesis. Subsections 1.1.1 to 1.1.3 below give a brief summary on the techniques 
used for the HIV-1 treatment and detection novel work completed. 
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1.1.1 Low level laser therapy on HIV infected cells 
Obtaining a cure for HIV-1 infection is still an endeavor of many researchers. Approximately 
six years after the discovery of HIV-1, zidovudine (ZVD), an antiretroviral drug was made 
available to infected individuals and now more than 20 antiretroviral drugs are in existence 
[11]. Their usage is effective in reducing the amount of the virus in infected individuals and 
since they do not cure the infection, they are a lifelong treatment that must be strictly adhered 
to [12]. For this reason, treatment intake interruption could lead to the emergence of HIV-1 
drug resistant strains, which might be difficult to treat [13]. Furthermore, using such drugs can 
cause some undesirable side effects, even though the drugs have been greatly improved over 
the years such that the severity of the side effects has been significantly minimized [14]. In an 
attempt to find a cure and explore the effectiveness of other forms of therapy with more reduced 
side effects, in this thesis low level laser therapy is used with the aim of reducing HIV-1 
infection in vitro via measurements conducted on infected TZM-bl cells. 
 
Low level laser therapy (LLLT) is a phenomenon which involves exposing tissue materials or 
cells to red and/or near infrared laser (light) with wavelengths ranging from 600 to 1,100 nm 
and low laser output powers of anything between 1 and 500 mW [15]. It has been used in the 
treatment of various medical conditions including diabetic wound healing, cancer, 
neurorehabilitation and more, but never on HIV-1 [16-19]. LLLT is an attractive form of 
therapy as its application stimulates physiological processes such as metabolism and 
proliferation which then enable the sick cells and tissue to heal naturally and at an optimum 
rate, thereby increasing the production of new cells, and enhances healing [20]. It is the 
stimulatory effects of LLLT that has encouraged its use in treating HIV-1 infection in TZM-bl 
cells as presented in chapter 2 of this thesis, with the anticipation that its use in HIV-1 infected 
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cells would increase the rate of growth for healthy cells (uninfected) to a point of outgrowing 
the infected ones.  
 
1.1.2 Optical trapping and spectroscopic analysis of HIV-1 infected cells 
Separately, HIV-1 diagnosis is conventionally done either immunologically to detect HIV 
antibodies or molecularly to detect viral molecules. These techniques have minimal 
discrepancies, they are effective and their use is valuable. Furthermore, these immunological 
and molecular methods are complex to run, since their application requires not only special 
bulky equipment, but also several reagents such as antibodies, antigens, enzymes, substrates, 
primers and polymerases in order to obtain the desired outcome. In addition, those that do not 
use sophisticated equipment; require the incorporation of some reagents or labelling for the 
antibodies in infected samples to be detected [21-23]. In order to simplify the detection of HIV-
1 infection, researchers in various fields of science continue to explore various diagnostic 
methods. Since it has been observed and proven that light in the form of laser can exert pressure 
or force onto matter in order to study and investigate several substances at cellular and 
molecular levels, in this thesis optical trapping, transmission spectroscopy and luminescence 
spectroscopy are employed for the detection of HIV-1 infection in both individual cells and 
cell suspension.  
 
Optical trapping is a highly sensitive technique that uses laser light forces for the non-invasive 
influence on nano- and micro- sized particles like cells. Using this technique, it is possible to 
diagnose diseases based on how light interacts with cells [24]. The dissimilarities detected on 
cells are commonly based on extracellular characteristics such as size, refractive index and 
shape [25].  
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Optical trapping setups can be coupled to other analytical systems for example spectroscopy 
and imaging setups in order to obtain as much detail as possible about the cell of interest.   
 
1.1.3 Single molecule analysis of HIV-1 infected cells 
Diagnosis of diseases is based on the detection of numerous substances on tissues and cells of 
the infected organisms. The detectable constituents include antibodies, molecules of the 
diseases causing agents and cellular or tissue damages introduced by the disease causing 
organism.  
 
In some instances the recognition of a disease requires comparing the condition of a specific 
molecule in both diseased and healthy states.  Similar to the detection of a disease causing 
agent molecule in infected cells, comparing molecules under two different settings (healthy 
and diseased) requires comprehensive analysis of either the diseased cells or the molecule of 
interest (which changes when there is an infection). Such experiments or detection mechanisms 
are known as single molecule analysis techniques. In the case of HIV-1 infection, single 
molecule analysis is done by detecting various viral components in infected cells. Since HIV-
1 is small with about 120 nm in diameter, the detection and analysis of its components requires 
the use of super resolution techniques. Such techniques enable the user to visualize 
fluorescently labelled molecules, thereby affording a platform to enhance disease diagnosis. 
Understanding the differences caused by a disease in cells has a potential to create platforms 
for the detection of abnormalities in the infected cells without using labelling dyes. Performing 
single molecule analysis in this study was a way of confirming the presence of HIV-1 infection 
as shown by other techniques employed in the work presented in this thesis. Super resolution 
microscopy has been extensively used in the field of HIV-1 research; however, future plans 
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include integration with optical trapping to enable studying and intricately interrogating 
individually trapped cells. 
 
1.2 Synopsis of thesis 
This thesis contains six chapters. Chapter 1 gives a brief overview of HIV-1 and epidemic 
related statistics reports. It continues summarizing the use of low level laser therapy, optical 
micromanipulation and single molecule analysis in HIV-1 related research. 
 
Chapter 2 focuses on the use of laser light of specific wavelengths in treating HIV-1 infection. 
Firstly, it gives a brief summary on the history of laser overview and the principles of laser by 
including the essential components necessary for laser production and modes of laser operation. 
Then, in a clear manner, chapter 2 describes mechanism of LLLT and the reasons behind its 
therapeutic effects on living organisms. The chapter also covers the interaction of light with 
biological matter. Furthermore, the applications of LLLT in the field of medicine are reviewed 
by looking into various medical areas where LLLT has been used. The chapter moves on to 
presenting challenges associated with HIV-1 treatment that led to the consideration of LLLT 
as a potential novel therapy. Finally, chapter 2 contains reports on the LLLT experiments 
conducted on HIV-1 infected TZM-bl cells and discusses the findings thereof.   
 
Chapter 3 describes in detail the forces governing the optical trapping technique. It begins by 
expressing mechanisms associated with the two approaches observed in optical tweezing of 
particles with different sizes, which are the Rayleigh and Mie regimes. The chapter goes on to 
explain how the optical trap efficiency is determined and also demonstrates optical trapping 
using a tightly focused 3D Gaussian beam.  
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In this chapter, the construction of the optical tweezing setup used in the current study is fully 
described alongside its use in trapping HIV-1 infected TZM-bl cells. The chapter then 
continues to discuss how optical trapping was coupled with transmission spectroscopy in order 
to detect HIV-1 infection in TZM-bl cells. 
 
Chapter 4 focuses on the detection of HIV-1 infection in TZM-bl cells using luminescence 
spectroscopy. Firstly, the chapter zooms in on the general luminescence mechanism as the 
production of luminescence is explained. Following that, the luminescence spectroscopy 
overview is defined by stating its principles together with essential elements of luminescence 
spectroscopy systems. Subsequent to that a brief review on various applications of 
luminescence spectroscopy is given. The chapter then looks into conventional methods of 
detecting HIV-1 infection in TZM-bl cells. In closing chapter 4 reports on the findings of the 
luminescence experiments conducted on HIV-1 infected cells and discusses the findings of the 
study while elaborating on the attractiveness of label free HIV-1 detection methods.  
 
Chapter 5 focuses on the detection of HIV-1 infection in TZM-bl cells by using structured 
illumination microscopy (SIM). The chapter opens by giving a historical background on the 
development of super resolution microscopy and how it has advanced the field of cell biology 
by allowing users to observe and study nanometer structures that were previously impossible 
to visualize. As the chapter continues, it then focuses on the mechanisms of SIM by looking 
into the generation of the Moiré pattern and the application of multi-wavelengths in order to 
get information inside the cell. This is followed by a brief assessment on how SIM has been 
used previously.  
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As the chapter closes, the attention is placed on how SIM was used in the study presented in 
this thesis and discusses how its use would contribute towards label free detection of HIV-1 
for smart diagnosis. 
 
To finish, chapter 6 summarizes the contents of the thesis, while putting special emphasis on 
its unique aspects and their potential impact in the development of laser driven diagnostic tools 
and laser based treatment modalities.  
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Chapter 2  
 
The effects of low level laser therapy on HIV-1 infection in the presence or 
absence of efavirenz 
 
Introduction 
The beginning of this chapter deals with the history of lasers and principle of laser production. 
Following this is the history of light therapies in conjunction with the mechanism of low level 
laser therapy (LLLT). Then a review on the suitable wavelengths for LLLT is given together 
with how biological matter absorbs laser during LLLT. Next, the use of LLLT in the treatment 
of various medical conditions is covered. Thereafter, challenges (leading to the investigation 
of how LLLT can affect HIV infection) associated with HIV-1 treatment are described. 
Furthermore, the construction of a simple LLLT experimental setup used is demonstrated and 
all its components such as the laser wavelength and power are described. Later in the chapter, 
the outcomes of using LLLT to treat HIV-1 infection in the presence or absence of antiretroviral 
treatment in a model system (TZM-bl cells) are discussed. 
 
2.1 Laser history and production 
2.1.1 Brief history of lasers 
Lasers are instruments producing intense beams of light that are monochromatic, highly 
collimated and coherent.  
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Owing to their properties, lasers are used in a variety of fields such as guidance systems, 
communication, photography, scanners, holography and medicine [1]. Their existence is 
attributed to Albert Einstein who hypothesized the process that makes laser possible by 
suggesting that besides absorbing and emitting light spontaneously, electrons could be 
stimulated to emit light of a specific wavelength [2]. Hence the invention of the acronym 
LASER, which stands for Light Amplification by Stimulated Emission of Radiation, as coined 
by Gordon Gould [3]. Einstein’s hypothesis was successfully put into practise by Theodore 
Maiman in 1960 when he constructed the first working ruby laser, which had silver-coated 
ends that were reflective to effectively serve as an optical resonator. Maiman’s laser was based 
on optical pumping of ruby crystal with a flash lamp, which generated a 694 nm red laser [4]. 
 
2.1.2 Principles of lasers 
Laser production is dependent on three basic components, which are the gain medium, energy 
source and optical resonator. Firstly, the gain medium; the source of optical gain within the 
laser and is capable of undergoing population inversion. It also determines both the laser type 
and laser wavelength. The medium can either be solid, gas, liquid or semiconductor diode. 
Secondly, the energy source, which provides the necessary energy and can either be optical, 
electrical or chemical. Finally, the optical resonator contains two parallel mirrors, which act as 
the feedback mechanism for the amplification of light. Mirror 1 denoted as M1 in figure 2.1 is 
highly reflective and allows no light to pass through, whereas mirror 2 denoted as M2 in Figure 
2.1 is partially reflective [2,3,5]. 
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Figure 2.1 Schematic representation of the principle of laser showing laser cavity and the laser operation, where 
R is the level of reflectivity [2,3,5].  
 
The lasing medium has atoms, and any atom has a central nucleus which contains protons and 
neutrons that are surrounded by electrons in different orbitals. These electrons jump from one 
orbital to another, as long as they absorb and emit energy in the form of photons, as determined 
by the equation:  
         𝐸 = ℎ𝑣          (2.1) 
Where E is the photon energy, h is Planck’s constant (6.63 x 10-24 J/s) and v is the photon 
frequency. Electrons in atoms are normally in a lower ground state and when they absorb light 
from the excitation source, the majority of electrons become excited and jump to a higher 
energy state, a process called population inversion. Electrons in this state are unstable and they 
quickly move back to the ground lower energy level through the emission process, which 
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happens in two ways. In spontaneous emission, electrons jump to their ground state while 
emitting photons in a random direction and a random phase, with a wavelength determined by 
the difference in energy of the two states. On the other hand, stimulated emission occurs when 
a photon collides with an atom in the excited state thereby releasing another stimulated photon, 
identical to the incident photon in its direction, phase and wavelength. The light energy is 
amplified until sufficient energy is built up for the release of laser light through the partially 
reflective mirror [5, 6].  
 
Lasers are classified according to their modes of operation, which are determined by the power 
output as well as their mode of operation i.e. continuous wave mode or pulsed mode. In the 
continuous wave (Figure 2.2A), the power output is continuous over time, whereas in the 
pulsed mode (Figure 2.2B) of operation the laser beam power output varies with respect to 
time, thereby giving high peak powers [7].  
 
 
Figure 2.2 Two modes of laser operation: (A) profile of continuous wave laser output and (B) represents the 
profile output of a pulsed laser which are normally high power lasers [7]. 
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Both these modes of laser operation have been widely used in laser therapy and in various 
applications in the Biophotonics field of study [8,9].  
 
2.2 Overview of low level laser therapy 
2.2.1 Discovery of light therapies 
The use of electromagnetic radiation (light) for medicinal purposes was established on the 
interaction of light from sources such as the sun, fire, electric discharge and bulbs with 
biological matter. The ancient Romans, Greeks, Egyptians, Chinese, Indians used sunlight for 
phototherapy and photo-chemotherapy to treat various skin ailments such as leukoderma, 
rickets and skin cancer [10]. Following the invention of the first laser by Theodore Maiman in 
1960, physicists and engineers began to investigate the potential applications of lasers for 
therapeutic purposes [8]. Only much later after this breakthrough, was the efficacy of laser as 
a form of treatment discovered [11]. The discovery was made when Endre Mester wanted to 
treat cancerous tumour cells on rats using laser. He instead noticed that applying laser light was 
not killing the tumour cells, but accelerated wound healing on surgical sites and also stimulated 
hair growth on shaved mice [11]. 
 
2.2.2 Mechanism of low level laser therapy 
Low level laser therapy is the application of red and near infrared lasers with wavelengths of 
600 to 1,100 nm at low powers of 1 to 500 mW for therapeutic purposes [12,13]. The 
mechanism of LLLT in the treatment of different medical conditions is not fully understood. 
However, unlike high power lasers that generate a thermal effect, low power lasers are used in 
LLLT to induce photochemical effects in cells, a phenomenon known as photo-bio-modulation 
or bio-stimulation.  
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Photobiology principle states that when light hits a chromophore the energy of the photons 
causes electrons to be excited and they move from a lower to a higher orbit. Several pieces of 
evidence show that these photochemical effects and electron shifts from one orbital level to 
another take place when mammalian cells absorb red and near infrared (NIR) light by 
mitochondrial chromophore, cytochrome c oxidase (CCO), and also by the photo-acceptors in 
the cell plasma membrane [14].  
 
In cells, LLLT causes the photo-dissociation of nitric oxide (NO) from CCO. Normally, 
stressed cells produce NO by mitochondrial NO synthase, displacing oxygen from CCO, which 
leads in a down regulation of cellular respiration and decrease in the production of adenosine 
triphosphate (ATP). So the dissociation of NO from CCO as a consequence of LLLT prevents 
oxygen displacement from CCO and promotes unobstructed cellular respiration. Therefore, the 
absorption of light stimulates the electron transport chain, which leads to the synthesis of ATP 
and cyclic adenosine monophosphate (cAMP), production of reactive oxygen species (ROS) 
and release of nitric oxide (Figure 2.3) [14-16].  
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Figure 2.3 Low level laser therapy mechanisms showing the different molecules involved in the therapeutic 
process [17]. 
 
Reactive oxygen species are the free radicals and reactive molecules that originate from 
molecular oxygen produced during electron transport as by-products [18]. It was presumed that 
these molecules only have damaging effects in cell components, however, recently it has been 
demonstrated that ROS play significant and beneficial roles in cell signalling processes and 
other physiological processes [19-20]. The induction of these molecules by LLLT have positive 
effects as they induce transcription factors like nuclear factor Kappa B (NF-κB) and activator 
protein-1 (AP-1), which in turn promote gene expression, thereby increasing protein synthesis, 
cell proliferation, cell migration, production of cytokines and growth factors, as well as 
increased tissue oxygenation [12-13,21-22]. Furthermore, the absorption of photons by 
mammalian cells regulates enzymatic activity and balances both intracellular and extracellular 
pH [23].  
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Yaakobi et al, 2001 [24] have also reported that LLLT increases antioxidant levels and plays a 
significant role in protein-protein interactions and establishing proper protein conformation as 
it stimulates the expression of heat shock proteins.  
 
2.3 Laser wavelength and biological material 
2.3.1 Laser light absorption in cells  
Biological materials such as cells are rich in proteins which are responsible for various roles; 
from transporting oxygen to intricate processes for example supplying a light-induced 
neurological response for vision. Amino acids as building blocks of proteins are aliphatic or 
aromatic [25]. The aliphatic amino acids absorb light of wavelengths shorter than 240 nm. On 
the other hand, aromatic amino acids absorb at wavelengths longer than 240 nm, but not within 
the visible region of the light spectrum. In addition to light absorption by amino acid residues, 
protein bonding in the form of polypeptide bonds and disulphide bonds are absorptive thus 
contributing to the total protein absorption of light [26]. To demonstrate classic absorption 
coefficients for various materials (water, whole blood, skin, cells), Figure 2.4 illustrates the 
absorption qualities of these materials [27].  
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Figure 2.4 The absorption spectra of some biological species. In the UV region, there is an increase in absorption 
of light with shorter wavelengths due to protein, DNA and other molecules. In the IR region, the increase in 
absorption of light with longer wavelengths results from the tissue water content. There is minimal absorption in 
the red and NIR [27]. 
 
Other biological materials that absorb light are purines and pyrimidines, which are building 
blocks of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). They absorb light 
between 230 nm and 300 nm, whereas carbohydrates absorb lower than 230 nm [28-29]. 
Despite the inability of water to absorb radiation in the between ultra-violet (UV) and the NIR, 
its absorption peaks emerge weakly above 1300 nm and its peaks are more pronounced at ≥ 
2900 nm and very strong absorption is at 10 000 nm [30]. Characteristically, cells exhibit 
notable transparency between 800 and 1100 nm; as such the majority of biological studies are 
done with lasers at these wavelengths [31].  
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2.3.2 Laser wavelengths suitable for LLLT 
Generally, the interaction of light with matter results in the scattering of the incident light rays, 
reflection, refraction, as well as absorption. For biological materials such as tissues, cells or 
organelles; the interaction of light with matter tends to induce a chain of events, which result 
in the manifestation of thermal, physical, chemical and mechanical effects or their combination 
[32]. To avoid undesirable outcomes and to ensure effective treatment when doing LLLT 
experiments, a suitable wavelength must be carefully selected. Tissues have an “optical 
window or therapeutic window” which runs between 650 nm and 1200 nm where the tissue 
permeation is optimal [32]. It should therefore be noted that LLLT in mammals, mammalian 
tissues and cells should be done using wavelengths between 600 nm and 1100 nm; covering 
the red and near infrared region of the electromagnetic spectrum [31]. Within the therapeutic 
window, various regions are more effective when used for a specific purpose, for instance, the 
600 to 660 nm treatment stretch is the best option for superficial scar tissue as it is absorbed 
close to the surface [33].  
 
It is also the preferred choice when treating more complex problems with no knowledge of the 
exact treatment location. The energy of this region can move through the body and interact 
with damaged cells in several body parts [33]. The 800 to 850 nm region is the best for deeper 
penetration and cellular interaction [32]. Lasers in this range are adjusted to interact with the 
mitochondria and elicit an increase in CCO and ATP, the two substances required in the 
remedial process [34]. While lasers within 905 nm interact with iron in hemoglobin and 
oxygenate the sick area. Oxygen is one of the essential molecules required for healing to 
successfully take place [35]. The 980 nm region is the peak of light interaction with water in 
the body and the energy generated here creates thermal gradient leading to an increase in 
circulation and blood flow.  
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The increase in circulation accelerates the natural healing process. However, the 980 nm lasers 
are great for laser surgery and less ideal for therapy because high energy level contained in this 
wavelength is converted into heat [36].  
 
2.4 Applications of low level laser therapy in biomedical sciences 
Few years after the invention of lasers in 1960, lasers were demonstrated to have therapeutic 
effects through the application of low power laser [8]. Since then LLLT has been used to treat 
various medical conditions including diabetic wounds, cancer, neurological challenges and 
many more. Section 2.4 focuses on reviewing the work that has been previously done with 
LLLT towards treating medical disorders in order to highlight its potential as it is used for HIV-
1 infection therapy in this study. 
 
2.4.1 Low level laser therapy in diabetic wound healing 
Diabetes mellitus is a metabolic disease in which glucose is underused and characterized by 
hyperglycaemia. Diabetes is a growing health concern worldwide, which is aggravated by poor 
diet in the modern culture due to an increase in fat intake and reduction in the consumption of 
fruit and vegetables leading to obesity. [37]. Diabetes sufferers are predisposed to several 
complications for example diabetic foot wounds, as they have been shown in many 
experimental and clinical studies [38]. Diabetic wounds are chronic due to impaired healing 
process and slow recovery because of physiological defects. Furthermore, diabetic ulcers are 
prone to poly-microbial infections; as diabetic patients have altered immune function and 
therefore increased susceptibility to infection and structural deformity [39]. Because of wound 
infections patients later develop gangrene, which normally results in limb amputation. Several 
factors such as decreased synthesis of collagen, production of growth factors, keratinocyte and 
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fibroblast proliferation contribute to poor wound healing in diabetic patients.  Non-healing 
wounds are associated with high treatment costs with little or no success [40]. Due to these 
challenges, the medical fraternity is looking into other alternative ways in order to improve and 
hasten tissue restoration in diabetic wounds.  
 
Owing to its photochemical effects, low level laser therapy is gaining popularity in treating 
diabetic wounds. Several studies have shown that low level laser therapy has great healing 
effects on diabetic wounds [41]. It has been reported that LLLT stimulates microcirculation 
and angiogenesis, which lead to improved blood circulation and reduced tissue damage. In both 
in vitro and in vivo studies, experimental and clinical studies, LLLT has been successfully used. 
In vitro the positive impact of phototherapy in cell cultures has been displayed in several ways. 
In a study conducted by Ayuk et al 2012 [41], the healing effect of LLLT was shown by a 
significant increase in cell viability, cell proliferation, collagen content and cell migration. In 
that study wounded fibroblasts were irradiated with 5 J/cm2 at 660 nm. In other study using 
human fibroblast, the wounded cells were exposed to a 636 nm diode laser at a density of 5 
J/cm2 and accelerated wound closure, normalization of cell function and increased proliferation 
were observed [42]. 
 
Great success when using LLLT has also been shown in in vivo studies: Yamany and co-
workers 2012 [43] performed a study with 30 females and male diabetic patients who were 
treated with a 850 nm laser for a period of four weeks. The laser treated group experienced 
reduction in pain and a significant improvement in foot skin microcirculation. In another 
experimental trial 13 patients who were unresponsive to other forms of treatment were treated 
with phototherapy combining both 660 nm and 890 nm.  
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Their leg ulcers were irradiated twice a week for three months and the wounds achieved 90 to 
100% recovery by day 90 in 75% cases, the healing was due to an increase in tissue granulation 
[44]. Literature suggests that for diabetic wound healing the best dose is 0.5 - 5 J/cm2 with 
wavelengths ranging between 600 and 700 nm, even though there are a number of successful 
treatments outside of this range [45].  
 
2.4.2 Low level laser therapy in cancer 
Cancer is a disease distinguished by abnormal growth and uncontainable cell division, which 
has a potential to infiltrate other parts and destroy normal body tissues [46]. It is caused by 
various factors such as inherited genetic defects, environmental factors, lifestyle and microbial 
infections [47]. Cancer affects any part of the body and usually named according to the affected 
body part. There are several available cancer treatments and the choice of treatment is 
dependent on factors such as cancer type, stage, patient’s state of health, and in some instances 
treatments are combined. Treatment options include chemotherapy, radiotherapy, 
immunotherapy, surgery, stem cell transplant, hormone therapy and targeted drug therapy. 
Other alternative means of treatment are being explored including LLLT. However, 
practitioners do not encourage the use of LLLT for cancer treatment with the fear that it might 
promote the proliferation of malignant cells, and worsen the condition. In cancer related cases, 
LLLT has been successfully used to prevent and manage the complications caused by the 
treatment and also to treat other conditions that the cancer sufferers might be burdened with 
[48-49]. 
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2.4.3 Low level laser therapy in neurorehabilitation 
Neurorehabilitation is a complicated medicinal path aiming to encourage recovery from a 
nervous system injury or sickness to lessen any functional alterations resulting from it [50]. 
Disturbances associated with the nervous system result in various neurological disorders such 
as stroke, brain tumours, epilepsy, dementia and many others [51]. Various effective treatments 
for neurological disorders are available. In addition to these available treatments, LLLT is also 
recommended and has been successfully used in many studies. In most studies associated with 
the application of LLLT, the radiation is applied to the head and that is known as transcranial 
LLLT [52]. Transcranial LLLT was shown to improve outcomes in patients with acute stroke 
when applied over the entire head surface (20 points in the 10/20 electroencephalographic 
system) nearly 18 hours after the stroke had occurred. This significant change was observed 
after only LLLT treatment and the improvement was still present even 90 days later. In that 
study a near infrared 808 nm laser delivering a fluence of 0.9 J/cm2 was used [52]. 
 
Transcranial LLLT has also been shown to successfully keep traumatic brain injury related 
neurological disorders in check with continuous treatments. In one case a 52 year old retired 
woman who had experienced multiple traumatic brain injuries and her brain MRI showed front 
parietal atrophy. Before beginning with transcranial (light emitting diode) LED treatments she 
had been medically incapacitated for 5 months. Following 4 months of nightly LED treatments, 
she went back to work full-time and discontinued medical disability leave [53]. For 
neurological abnormalities, the best wavelength range seems to be between 800 nm and 1000 
nm, as these wavelengths can penetrate the scalp and skull and reach the brain [54].  
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2.4.4 Low level laser therapy in other medical conditions 
Above and beyond the three medical conditions discussed above, LLLT has been utilized for 
the treatment of many other medical conditions such as hair loss, skin related problems, and 
pain. In this section I will give a short review of what has been achieved with LLLT for the 
treatment of other medical conditions. After Mester’s observation of mice hair growth due to 
laser irradiation [8], several other studies using mice models demonstrated the hair growth 
effects of LLLT [55-56]. The stimulatory effects of LLLT on hair growth were also observed 
in clinical trials: In one study 24 male patients suffering from androgenetic alopecia were 
treated with 655 nm and 780 nm laser for ten minutes a day over a period of 14 weeks. 
Subsequent to the treatment an increase in hair density was observed and 83 % of the patients 
were pleased with the treatment [57]. When the HairMax LaserComb® device was used in two 
different studies; all the 145 patients who participated experienced a substantial improvement 
in overall hair growth and significant reduction in hair loss [57-59].  
 
A study conducted by Aziz-Jalali et al, 2012 [33], where LLLT using a 630 nm InGaAs laser 
at 12 J/cm2 showed considerably reduced active acne abrasions after several weeks of therapy 
over a 10 week period on 28 study participants. The success of this study was attributed to the 
red light’s ability of regulating the secretion of sebum by sebaceous glands and also changing 
keratinocyte behavior. Moreover, irradiation with red laser is associated with a reduction in 
inflammation due to the modulation of cytokines by macrophages and others cells [60]. In one 
study sunburn symptoms associated with skin burning, redness, peeling and swelling were 
significantly reduced after the 10 patients had received 590 nm LED treatment for three days 
[61]. Skin rejuvenation has also been achieved when using LLLT. It has been shown by the 
reduction in the appearance of wrinkles and it is associated with an increase in the production 
of pro-collagen, collagen, proliferation of fibroblasts following exposure to low power laser 
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irradiation in both in vitro and in vivo studies [62-64]. The efficacy of LLLT on skin related 
disorders has been seen in the treatment of psoriasis that had been resistant to conventional 
therapy. That was achieved by sequentially treating the patients with 830 nm and 630 nm 
wavelengths with 20 minute sessions over a 4 weeks and no adverse side effects were observed 
[65].  
 
LLLT has been extensively used for various kinds of pain such as osteoarthritis, neck pain 
frozen shoulder and orthodontic pain [66-76]. In a double-blinded randomized placebo-
controlled trial, participants who were treated with LLLT experienced a significant reduction 
in knee associated pain compared to those who were treated with sham treatment [68]. The 
pain associated with frozen shoulder can be effectively reduced by LLLT while the inability to 
move the arm can be treated by corticosteroid injections and other forms of treatment [72]. 
Orthodontic procedures are usually followed by pain which usually forces patients to interfere 
with their treatment [75-76]. However, LLLT has been shown to successfully produce 
analgesic effects in various clinical applications in controlling orthodontic post adjustment pain 
[76].  
 
It is worth noting that the majority, if not all the medical conditions that have been treated with 
LLLT are non-communicable disease. The focus of the work presented in this thesis is the use 
of LLLT in the treatment of HIV-1, which is a communicable disease that has burdened the 
global health sector for more than three decades. 
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2.5 Challenges with HIV-1 treatment 
Great strides have been made to treat HIV-1 since its discovery in the early 1980s. These 
victories are largely due to the availability and use of effective antiretroviral drugs. However, 
HIV-1 treatment struggles are far from being over because even the current HIV-1 treatment 
has a few challenges such as high cost, lifelong intake and the development of resistant strains 
of HIV-1 that render some antiretroviral drugs ineffective. In sections 2.5.1 to 2.5.3; these 
challenges will be discussed. 
 
2.5.1 Antiretroviral Spending in South Africa 
South Africa has the highest expenditure on HIV-1 treatment programme in the world [77]. 
Between 2014 and 2015 the national department of health spent $350 million on antiretroviral 
treatment for just over 3 million people living with HIV-1 [78-79]. By the end of 2016 that 
number had increased to 3.9 million individuals. However, this bleak picture of expensive 
treatment was changed when a pricing agreement was reached between the Kenyan and South 
African governments in collaboration with UNAIDS, the Clinton Health Access Initiative, 
Unitaid, the Bill & Melinda Gates Foundation, the United Kingdom’s department for 
International development, the Global Fund to fight AIDS, TB & Malaria and the U.S. Agency 
for International Development. This new collaboration aimed to accelerate and bring about 
significant reduction in the national expenditure on the antiretroviral therapy programme by 
the introduction of a state-of-the-art pill which is a combination of three antiretroviral drugs. 
The backbone of this pill is dolutegravir, which is combined with tenofovir and lamivudine and 
is commonly referred to as TLD representing the first letters of each drug contained in the pill.  
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Its introduction will not only bring about economic benefits, but it will also come with clinical 
benefits as it has less side effects and therefore better tolerated than efavirenz and nevirapine 
[80-83]. With this new pill the South African government is estimated to save $900 million 
over six years [81].  
 
2.5.2 Antiretroviral therapy as a lifelong treatment 
Since HIV infection is a chronic medical condition, it requires a lifetime treatment and the 
current treatment is not a cure, but a means of keeping the virus in check without being able to 
replicate. The presence of latent viral reservoirs in infected individuals makes the virus 
incurable. In the reservoirs the virus lies dormant, transcriptionally silent without replication 
and production of viral progeny until reactivation by stimuli. Some infected cells in the 
reservoirs escape immune detection and elimination. Reservoirs can be found all over the body, 
including digestive tract, brain and lymph nodes. Due to the presence of these dormant sites, 
antiretroviral drugs must be taken with strict adherence without any interruption. Treatment 
interruption poses a major risk of activating the dormant virus to start replicating [84-85]. 
 
Furthermore, due to the error prone character of HIV-1 reverse transcriptase enzyme, every 
lytic cycle gives rise to virions containing 5 to 10 bases that are different from the parent virus. 
This variation in viral sequence is commonly known as drug resistance mutation, which can 
cause treatment failure [86]. With the emergence of drug resistant strains of HIV, there is an 
increase in costs as drug resistance tests must be conducted to establish which of the drugs in 
the cocktail has become ineffective. In addition, a new treatment regimen would have to be 
used and in some instances, it might be challenging to treat the infection with the already in 
use drug combinations [87].  
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Due to the challenges associated with HIV-1 treatment, the study presented in this chapter was 
designed as means of looking into other forms of therapy for HIV-1 infection. Similar to other 
research studies in HIV-1 treatment, the current study is looking into discovering treatment that 
can either completely eradicate HIV-1 infection or reduce costs and any other complications 
associated with HIV-1 treatment. From section 2.6 to 2.9, I will address the aims of the study, 
the experiments conducted and the outcomes thereof. 
 
2.6 Applications of low level laser therapy in HIV-1 in the absence or presence of 
efavirenz 
To date, extensive research has been conducted towards finding treatment for HIV-1 infection 
and antiretroviral drugs that reduce the virus to undetectable levels are available [88]. Since no 
cure has come to the fore, researchers continue with investigations towards obtaining treatment 
that would completely eradicate HIV. The current study then seeks to unpack the significance 
of applying LLLT only on HIV-1 infection and also combining LLLT with antiretroviral drugs 
as a potential therapy; in this case efavirenz was the drug of choice. Efavirenz is always used 
in conjunction with other drugs in highly active antiretroviral therapy (HAART) [89]. It is a 
non-nucleoside reverse transcriptase inhibitor (NNRTI), which binds at a distinct site away 
from the enzyme active site thereby hindering the enzyme polymerase activity [90]. It prevents 
HIV-1 replication by blocking the reverse transcriptase enzyme from converting the viral 
genomic RNA into complementary DNA (cDNA), which then becomes integrated into the host 
DNA [91].  
 
The experiments comprized of three groups of TZM-bl cells (HIV infection model); the first 
group was uninfected TZM-bl cells that were not infected with the pseudovirus (G1), the 
second group were infected cells (G2) and the third group were infected cells that were 
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incubated with efavirenz (G3). During the experiments, for G2 and G3, the TZM-bl cells were 
infected by the ZM53 pseudovirus in a tissue culture dish containing cells and growth media. 
Both the infected (G2 and G3) and uninfected (G1) TZM-bl cells were incubated at 37°C, 5% 
CO2 and 85% humidity for 48 hours. After 48 hours of incubation, the G3 cells were prepared 
by adding 20 µg/ml of efavirenz to the infected cells and further incubated for 30 minutes at 
37°C. The G1, G2 and G3 cell samples were separately irradiated at doses 2 to 10 J/cm2. 
Irradiation using a 640 nm laser was conducted in a dark room in order to prevent 
contamination from background light. 
 
All experiments were conducted in triplicates and repeated three times (n = 3), with average 
values used to plot the graphs. Non-parametric one way analysis of variance was used to 
investigate the statistical significance of data and shown on graphs by asterisks*. The results 
were considered significantly different when P < 0.05. Statistical differences between the 
untreated controls and experimental groups are shown in graphs as * P < 0.05, ** P < 0.01, 
and *** P < 0.001 and dispersion bars represent standard error. All the non-irradiated cells 
were used as controls; with uninfected cells being the negative control (G1 = NC), infected 
cells being the positive control (G2 = PC) and the infected cells incubated efavirenz considered 
the drug control (G3 = DC). 
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2.7 Low level laser therapy experimental setup 
The TZM-bl cells were irradiated using a 640 nm diode laser (Coherent), with a laser power of 
30 mW at the sample area using fluences of 2 to 10 J/cm2. Table 1.1 shows laser parameters 
used for irradiation experiments.  
 
Table 2.1 Laser irradiation parameters 
                                              Laser parameters 
Wavelength (nm) 640 
Power Output at the sample (mW) 30  
Type of emission Continuous wave 
Illuminated area (cm2) 4.2  
Irradiation times (s) 606, 1263, 1920, 2526, 3183 
Fluences (J/cm2) 2, 4, 6, 8 and 10 
Beam profile Gaussian 
 
The fluence (∅), power (P) and the irradiated area A were parameters used to determine the 
duration of cell exposure to laser using the following formula: 
 
                                                            𝑡 =
∅×𝐴
𝑃
                                                              (2.2) 
 
Through the laser pulse energy in joules J and the effective focal spot area in cm2, it was 
possible to determine different fluences used, via this formula: 
 
                                                          Fluence =
J
cm2
                                                   (2.3) 
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After laser irradiation of cells through the setup shown in Figure 2.5, the culture dishes were 
incubated for 24 hours at 37 °C in 5% CO2 and 85% humidity, followed by biological assays.  
 
 
Figure 2.5 The experimental setup for the LLLT studies depicted. The diameter of the 640 nm diode laser was 
expanded using a two lens telescope (L1 = 25.4 mm and L2 = 500 mm) from 1.2 mm to 24 mm. The laser beam 
was reflected using a highly reflective silver mirror (M) to fill the surface area of the petri dish with a monolayer 
of TZM-bl cells.  
 
2.8 The effects of LLLT in HIV-1 infected TZM-bl cells 
2.8.1 Assays for the effects of LLLT, HIV-1 infection and efavirenz on cells 
2.8.1.1 Cell morphology and Reactive Oxygen Species 
The results in Figure 2.6 show the changes in cell morphology and production of the reactive 
oxygen species (ROS) following HIV-1 infection, laser irradiation and addition of efavirenz 
on TZM-bl cells. The assessment of cell morphology using the bright-field microscope showed 
that both irradiated and non-irradiated uninfected cells in Figures 2.6 A and G were healthy 
and grew as a monolayer. Also, there was no ROS production in both irradiated and non-
irradiated uninfected cells as exhibited by the absence of green fluorescence in Figures 2.6 D 
and J.  
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Both the irradiated and non-irradiated infected cells in Figures 2.6 B and H showed signs of 
cell stress as the cells became round with some detached and floating around. A similar pattern 
of stressed cells was observed in both irradiated and non-irradiated infected cells in the 
presence of efavirenz at Figures 2.6 C and I. With regards to ROS production in infected 
irradiated and non-irradiated cells in Figures 2.6 E and K there was increased ROS production. 
ROS production also took place in both irradiated and non-irradiated infected cells with drug 
as demonstrated in Figures 2.6 F and L. 
 
 
 
 
37 
 
 
Figure 2.6 Cell morphology and ROS production in TZM-bl cells: pictures A to C and G to I show the cell 
morphology of (A and G) uninfected non-irradiated, (B and H) infected non-irradiated and (C and I) non-irradiated 
infected with drug. Images D to F and J to L are the ROS production images where, (D and J) uninfected non-
irradiated, (E and K) infected non-irradiated and (F and L) non-irradiated infected with drug. 
 
2.8.1.2 Cell viability detection by adenosine triphosphate assay 
Cell viability was assessed using the ATP assay (Figure 2.7) in order to determine the effects 
of HIV infection, exposure to efavirenz and laser irradiation on the cells. The results obtained 
showed that uninfected cells irradiated at 2 to 6 J/cm2 displayed no significant changes in cell 
viability as compared to the negative control (NC).  
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Figure 2.7 Cell viability results of uninfected, HIV-1 infected and HIV-1 infected TZM-bl cells treated with 
efavirenz. Cells were irradiated with increasing fluences of 2, 4, 6, 8 and 10 J/cm2. Significant differences between 
controls (NC = negative control, PC = positive control and DC = drug control) and experimental groups are 
represented on the graph as (*) = P < 0.05 and (**) = P < 0.01. Error bars represent the standard error of the mean 
where n = 3.  
 
On the contrary, at fluences 8 and 10 J/cm2 there was a significant reduction in ATP levels in 
uninfected cells. Infected cells irradiated at fluences of 8 and 10 J/cm2 also showed significant 
changes in cell viability when compared to positive control (PC).  
No significant changes in cell viability were noted in infected cells irradiated at fluences of 2, 
4, and 6 J/cm2 when compared to PC. Infected cells containing efavirenz and laser irradiated 
at 6, 8 and 10 J/cm2 showed a significant reduction in cell viability when compared to the drug 
control (DC), while laser irradiation at 2 and 4 J/cm2 showed no significant changes. The PC 
(cells infected with virus) showed the highest cell viability followed by NC (cells with no 
infection) and then DC (cells infected and treated with efavirenz).  
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Infected cells irradiated at 2, 4, 6 J/cm2 showed a decrease in ATP levels as compared to 
uninfected cells irradiated with the same fluence, while at fluences 8 and 10 J/cm2, infected 
cells showed an increase in ATP levels. Infected cells containing efavirenz showed the lowest 
ATP levels both in the presence and absence of laser irradiation when compared to the 
uninfected and infected cells. 
 
2.8.1.3 Cell proliferation detection by MTT assay  
Cell proliferation (Figure 2.8) was assessed using the MTT assay in order to determine the 
effects of HIV infection, treatment with efavirenz and exposure to laser irradiation on the 
proliferation of TZM-bl cells. The MTT assay absorbance was measured at 600 nm using a 
luminometer. 
 
 
Figure 2.8 Cell proliferation of uninfected, HIV infected and HIV infected TZM-bl cells with efavirenz. The cells 
were irradiated with increasing fluences of 2, 4, 6, 8 and 10 J/cm2. Significant differences between controls and 
their respective control groups are represented on the graph as (*) = P < 0.05 and (**) = P < 0.01. Error bars 
represent the standard error of the mean where n = 3. 
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Data obtained confirmed that uninfected cells irradiated at 2 to 10 J/cm2 showed no significant 
changes in cell proliferation in comparison to the NC. Infected cells irradiated with fluences 6 
and 10 J/cm2 showed a significant reduction (P < 0.01) in cell proliferation when compared to 
the PC. However, there was no significant difference between the infected cells irradiated at 8 
J/cm2 and the PC. Infected cells containing efavirenz and laser irradiated at 2 and 4 J/cm2 
showed no significant differences in cell proliferation as compared to the PC, while those 
irradiated at 6 to 10 J/cm2 proliferated significantly poor (P < 0.05). The negative control had 
the highest proliferation rate followed by the PC and then DC. A similar pattern was also 
observed in irradiated cells at fluences 2 to 10 J/cm2. 
 
2.8.1.4 Cell membrane integrity detection by lactate dehydrogenase assay  
The cell membrane integrity was examined using lactate dehydrogenase (LDH) assay (Figure 
2.9) in order to determine the effects of HIV infection, efavirenz and treatment with laser light 
of different doses on TZM-bl cells.  
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Figure 2.9 Cell membrane damage of uninfected, HIV infected and HIV infected TZM-bl cells with the drug 
efavirenz. Cells were irradiated with increasing fluences of 2, 4, 6, 8 and 10 J/cm2. Significant differences between 
the controls and the respective experimental groups are represented in the graph as (*) = P < 0.05 and (**) = P < 
0.01. Error bars represent the standard error of the mean where n = 3. 
 
LDH is a cytosolic enzyme that is released from cells when cell membranes are damaged. 
Uninfected cells irradiated at 2 to 10 J/cm2 showed no significant differences in LDH levels in 
comparison to the NC. Infected cells irradiated with fluences of 6, 8 and 10 J/cm2 showed 
significantly high LDH levels as compared to PC (P < 0.05, P < 0.01 and P < 0.05), while there 
were no significant differences between PC and infected cells irradiated at 2 and 4 J/cm2. 
Infected cells containing efavirenz and laser irradiated at fluences of 2 to 10 J/cm2 showed 
significantly high LDH levels when compared to the DC (P < 0.01 and P < 0.05). The DC had 
the highest LDH levels followed by PC and NC, and a similar pattern was also seen in all 
experimental groups. 
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2.8.2 Luciferase assay to detect effects of LLLT and efavirenz on HIV-1 infection in TZM-
bl cells 
Luciferase assay is a tool generally used to study gene expression and it gives quantitative 
measurements. In this study the luciferase assay was used to monitor HIV-1 infection (Figure 
2.10) and to evaluate the effects of combining the drug efavirenz and laser irradiation as 
potential treatment for HIV-1 infection. It was used because TZM-bl cells contain a luciferase 
gene which is expressed when HIV-1 infection has taken place. By measuring luciferase 
activity, which is directly proportional to viral particles that infected a cell using relative 
luminescence units (RLUs) HIV-1 infection can be determined. The higher RLUs indicate high 
levels of infection, whereas lower RLUs indicate low infection levels. In the absence of 
infection there is no luminescence produced because the luciferase gene in cells would not be 
expressed [92-93].  
 
 
Figure 2.10 Luciferase assay monitored HIV infection in TZM-bl cells. TZM-bl cells were irradiated at 2 to 10 
J/cm2. Significant differences between controls and their respective control groups are represented on the graph 
as (**) = P < 0.01 and (***) = P < 0.001. Error bars represent the standard error of the mean where n = 3. 
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Briefly, uninfected cells irradiated at 2 to 10 J/cm2 showed no significant differences in 
luciferase activity as compared to the NC as shown in Figure 2.10. Infected cells irradiated at 
2 to 10 J/cm2 showed a significant reduction in luciferase activity (HIV infection) when 
compared to PC (P < 0.001). Infected cells containing efavirenz and laser irradiated at 2, 4, 6, 
8 and 10 J/cm2 also showed significantly low levels of HIV infection when compared to DC (P 
< 0.01, P < 0.01, P < 0.001 and P < 0.001 respectively). PC showed the highest levels of HIV 
infection followed by DC and then NC and a similar pattern was seen in all laser irradiated 
cells. 
 
2.8.3 Flow cytometry for the detection of cell death pathway induced by HIV infection, 
LLLT and efavirenz 
The Annevin V-Flourescein isothiocynate commonly known as Annexin V-FITC apoptosis kit 
was used to distinguish between apoptotic and necrotic cells using flow cytometry. Figure 2.11 
shows flow cytometric dot plots differentiating between live, necrotic, late apoptotic (dead) 
and early apoptotic cells.  
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Figure 2.11 Propidium iodide/Annexin V FITC staining used to assess the mode of cell death in both irradiated 
and non-irradiated cells. 
 
Early apoptotic cells were positively stained with annexin V-FITC (lower right quadrant), 
necrotic cells were positively stained with propidium iodide (PI) (upper left quadrant), dead 
cells were stained with both annexin V-FITC and PI (upper right quadrant) while live cells are 
not stained (lower left quadrant). Uninfected cells irradiated at 2 to 10 J/cm2 showed no changes 
in cell population when compared to the uninfected control cells and the majority of the cell 
population was live cells. Infected cells irradiated at 2 to 10 J/cm2 also showed no changes in 
cell population when compared to infected control cells, except for cells irradiated with 8 J/cm2. 
These cells had a significantly reduced proportion of viable cells 1.3% (P < 0.05) and a 
significant increase in dead cells 86.6% (P < 0.001) and necrotic cells 11.7% (P < 0.001).  
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Table 2.2 Percentage of various cell populations after staining with propidium iodide/annexin V-FITC 
Groups Lives cells (%) Dead cells (%) 
Apoptotic cells 
(%) 
Necrotic cells 
(%) 
Uninfected 93.6 ± 2.7 1.37 ± 1.3 1.27 ± 0.81 3.7 ± 0.84 
2 95 ± 0.9 1.1 ± 0.5 0.7 ± 0.35 3.17 ± 0.84 
4 92.2 ± 2 2.26 ± 1.39 1.4 ± 0.23 4.1 ± 1.07 
6 92.3 ± 2.01 2.46 ± 1.46 1.83 ± 0.61 3.33 ± 0.38 
8 93.5 ± 0.63 1.83 ± 0.99 1.23 ± 0.12 3.36 ± 0.73 
10 92.3 ± 1.6 1.6 ± 0.8 1.06 ± 0.5 5.16 ± 2.96 
     
Infected 6.43 ± 1.29 38.33 ± 1.56 0.43 ± 2.72 54.96 ± 2.72 
2 4.53 ± 1.71 28.73 ± 4.29 0.36 ± 0.08 66.33 ± 5.91 
4 2.3 ± 1.21 46.13 ± 3.13 0.3 ± 0.15 51.23 ± 3.89 
6 2.3 ± 1.38 73.37 ± 8.58 0.03 ± 0.03 24.2 ± 7.46* 
8 1.3 ± 0.68* 86.8 ± 3.66*** 0.2 ± 0.1 11.7 ± 3.09*** 
10 1.9 ± 0.11 58.46 ± 6.91 0.46 ± 0.36 35.53 ± 8.74 
     
Infected and 
drug 3.67 ± 0.29 37.2 ± 5.48 0.2 ± 0.11 58.97 ± 5.65 
2 2.2 ± 0.34* 55.56 ± 4.08 0.4 ± 0.31 41.83 ± 3.51 
4 3.53 ± 1.52 56.87 ± 8.48 0.33 ± 0.28 39.17 ± 6.83 
6 1.83 ± 0.06* 74.83 ± 4.10** 0.37 ± 0.12 22.97 ± 4.18 
8 3.1 ± 1.00 78.33 ± 7.97* 1.37 ± 0.35 17.2 ± 7.27* 
10 1.97 ± 0.42* 87.9 ± 4.07** 0.9 ± 0.55 9.23  4.27** 
Significant differences between controls and their respective control groups are represented on the graph as (**) 
= P < 0.01 and (***) = P < 0.001. Experiments were repeated 3 times (n=3). 
 
All the infected cells that were treated with efavirenz showed a reduction in the live cell 
population. However, the number of dead cells increased with the increase in fluence, with 
non-irradiated group showing smallest populations of both dead and apoptotic cells, but the 
highest on necrotic cells. In Table1.2, percentages of various cell populations i.e. live, dead, 
apoptotic and necrotic cells are shown. The data explicitly shows that the uninfected group of 
cells (G1) had a higher number of live cells compared to the infected groups (G2 and G3). Both 
G2 and G3 had a higher number of necrotic cells and dead cells. 
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2.9 Discussion 
The introduction of antiretroviral agents has seen a million lives spared from the unmerciful 
scourge of HIV-1 infection on the human race. Nonetheless, there is still a dire need to find a 
form of therapy that would completely eradicate HIV and minimize the side effects caused by 
the combination of different drugs in each HAART regimen. The efavirenz used in the current 
study is a first generation NNRTI that has been in use as a first line regimen [94-96]. Since its 
first use in the late 1990s, efavirenz is still part of the treatment used by HIV infected 
individuals resulting in viral suppression even after years of using it and this is a clear indication 
that it is effective against HIV [96]. In this study, we tested a combination of two unrelated 
therapies i.e. LLLT and the drug efavirenz against HIV infection in TZM-bl cells (model of 
HIV infection) for the first time. 
 
The TZM-bl cells are susceptible to HIV primary isolates and molecularly cloned Env-
pseudotyped viruses, like the ZM53 virus used in the current study. When HIV infection has 
taken place in TZM-bl cells, the reporter gene expression is induced by the HIV Tat protein, 
as the reporter genes are tat-inducible. The presence of reporter genes in TZM-bl cells enables 
the user to determine whether there is HIV infection or not. Both the negative control and all 
the irradiated uninfected cells showed no luciferase activity, which was expected as luciferase 
activity in TZM-bl cells is only induced when HIV infection has taken place [92].  
 
The little luminescence detected in uninfected cells is attributed to the auto-luminescence 
which is present at negligible levels in most mammalian cells [97]. The notably high levels of 
luciferase activity as shown by RLUs in the presence of HIV was a clear indication that TZM-
bl cells are permissive to HIV infection and the ZM53 virus used was infectious.  
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A significant reduction in HIV-1 infection (P < 0.001) was observed in irradiated infected cells 
as shown by a red bar in Figure 2.10. A further reduction (P < 0.01 and P < 0.001) was seen 
when the infected cells were exposed to efavirenz and laser irradiation as shown by the green 
bar in Figure 2.10, when compared with the drug control, where infected cells were exposed to 
the drug for 30 minutes, but were not irradiated. Even though the reduction of HIV infection 
was expected in the presence of an antiretroviral agent, the noteworthy reduction of infection 
when the two therapies were combined was a rejuvenating factor, as it is apparent that the 
combination of the two therapies has potential in fighting HIV infection.  
 
Having assessed how irradiation and efavirenz affect HIV infection in TZM-bl cells, it was 
essential to establish how the two therapies affected the health of TZM-bl cells. This was done 
by evaluating cell morphology using light microscope, ROS production detected with 
fluorescence microscope, cell viability (ATP assay), cell proliferation (MTT assay) and cell 
membrane damage (LDH assay). In Figure 2.6 cell morphology results showed visible 
differences between infected and uninfected cells, and the presence of floating cells as shown 
in Figure 2.6 B, C, H and was a clear evidence that HIV has cytopathic effects on virus 
permissive cells [98]. The cell morphology results compare with the MTT assay results in 
Figure 2.8 as the uninfected cells proliferated better than the infected cells.  
 
Furthermore, the absence of significant differences between the negative control and 
uninfected cells irradiated at 2 to 10 J/cm2 was indicative of irradiation having no noteworthy 
effects on uninfected TZM-bl cells. The lack or minimal effects of irradiation on cells has been 
previously observed on other cell lines as the impact of irradiation on different cell types differs 
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from one cell type to another [99]. Various factors such as wavelength and fluence have an 
impact on the response of cells and determine the success or failure of LLLT [12].  
 
According to MTT results, infected cells in the presence or absence of efavirenz showed no 
significant changes in cell proliferation after irradiating at 2 and 4 J/cm2 when compared to 
their respective control groups (PC and DC). On the contrary, a significant reduction in cell 
proliferation was seen at fluences of 6 to 10 J/cm2 except for infected cells irradiated at 8 J/cm2. 
The reduction can be attributed to the increase in fluence, which would have enhanced the 
undesirable effects of the infection and efavirenz on the cells. A similar observation was noted 
in the LDH assay for infected cells in the absence of efavirenz, as there were no significant 
differences between the PC and infected cells irradiated at 2 to 4 J/cm2, while there was a 
significant increase in LDH levels at fluences 6 to 10 J/cm2. However, in the LDH results there 
were significantly high levels of LDH at all fluences in cells that contained efavirenz, which 
clearly shows the detrimental effects that the drug had on the cells. The undesirable effects 
associated with the use of efavirenz in mammalian cells include endoplasmic reticulum stress 
and autophagy in endothelial cells and the generation of ROS [100-101]. 
 
With the understanding that HIV infection causes cytopathic effects in cells, one would have 
expected that HIV infected cells would have significantly lower ATP levels in comparison to 
the uninfected cells. However, the results showed that there were no significant differences 
between ATP levels in infected and uninfected cells as well as at fluences of 8 and 10 J/cm2. 
ATP levels in infected cells were slightly higher than in uninfected cells, and this was attributed 
to the role of the HIV-1 p2 peptide, which intensifies the virus’ acute infection as it increases 
intracellular ATP production [102].  
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The significant reduction in cell viability levels in the presence of efavirenz is in correlation 
with what is known about the detrimental effects of efavirenz in cells [101].  
 
Flow cytometry was done to determine the mode of cell death associated with HIV infection, 
LLLT and the use of efavirenz. The flow cytometry results of uninfected cells in Figure 2.11 
showed expected results as there was a high number of live cells (88 to 96%) compared to 
apoptotic, necrotic and dead cells that had low populations ranging from 0.1% to 11%. The 
presence of dead or dying cells in a healthy sample is also not an alarming observation as cells 
die when they are old and are replaced by new ones or when they have been damaged [103]. 
The dying of old cells in order to be replaced by new ones is a programmed form of cell death 
that is commonly known as apoptosis. In addition, since TZM-bl cells are adherent, during 
passaging they get exposed to trypsin-EDTA to enable them to detach from the culture flask 
and a small population of cells gets damaged during this process, thereby leading to cell death. 
Unlike uninfected cells, the infected cells had a small population of live cells ranging from 0 
to 5.4%, while necrotic and dead populations had the highest numbers and the apoptotic 
population had no greater than 13%. This observation correlates with the other assays where 
HIV infection, addition of efavirenz and laser irradiation at some fluences had detrimental 
effects on TZM-bl cells. It also became apparent that cell death in this study was mainly due 
to necrosis which correlates with literature where necrosis has been mostly observed in vitro, 
while apoptosis seems to be the most common form of cell death observed in vivo [104]. 
Furthermore, cell death by necrosis is also in correlation with the fact that necrosis occur as a 
consequence of infection or injury.  
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There was no ROS detected in both irradiated and non-irradiated uninfected cells Figure 2.6 D 
and J, which is similar to what was previously observed by Basso, where there was no 
detectable ROS production in healthy irradiated cells [99]. This result also correlates with what 
was observed in other biological assays conducted in this study, where there were no significant 
changes and differences between irradiated and non-irradiated uninfected cells. On the other 
hand, the results showed what was speculated in the late 1980s that HIV infection is associated 
with ROS production, as cells infected with HIV (both irradiated and non-irradiated) showed 
the generation of ROS [105]. Non-irradiated infected cells with or without efavirenz showed 
the same fluorescence pattern with irradiated cells indicating production of ROS. Based on 
these findings, it is clear that the ROS production was caused by HIV infection. Finally, 
following combining LLLT and the drug efavirens for the first time in HIV treatment, an 
elaborate decrease in infection was detected calling for future research via this novel treatment 
regime even in-vivo. 
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Chapter 3 
 
Optical trapping and transmission spectroscopy for HIV-1 detection in 
TZM-bl cells 
 
Introduction 
In this chapter, a short outline on various optical trapping modes such as counter propagating 
beam trap, levitation trap and single beam trap is given. That is then followed by a section in 
which forces responsible for optical trapping are explained. In addition to that, mechanisms 
used to trap Rayleigh and Mie particles are clarified, followed by a detailed description on how 
optical trapping efficiency is determined using the Q value method. Next, general principles to 
be considered in the construction of an optical trapping system using a Gaussian beam are 
outlined. As the chapter winds up, the construction of the optical trapping system and its use 
to trap TZM-bl cells is reported, followed by both the description and the discussion of HIV-1 
infection detection in TZM-bl cells using optical trapping coupled to transmission 
spectroscopy. 
 
3.1 Optical traps 
3.1.1 Outline of the various optical trapping modes 
Optical trapping is a powerful and versatile method that uses laser light to manipulate 
microscopic particles using devices that are commonly known as optical tweezers or optical 
traps [1].  
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Since light (in the form of a photon) carries momentum that is proportional to its energy, when 
light is reflected, refracted or absorbed by a particle it undergoes a change in momentum. In 
turn, the particle also experiences a similar change in momentum due to the force exerted on it 
[2, 3]. Therefore, the optical trap is based on the momentum transfer associated with the 
redirection of light as it interacts with a dielectric particle. The redirection or refraction results 
in a force that holds the particle in a three-dimensional (3D) manner [1]. Since optical traps 
exert very small forces (in the order of picoNewton, 10-12 N), their use is effective and sufficient 
for the non-invasive manipulation of microscopic particles [4]. For successful trapping of the 
particles, the refractive index of the particle ought to be higher than that of the surrounding 
medium [2]. Another important factor, for optical trapping to take place, a laser beam should 
be tightly focused through a high numerical aperture microscope objective for the generation 
of gradient forces counteracting the scattering forces in the propagation direction [5]. 
 
The first three trapping geometries were demonstrated by Arthur Ashkin as revealed in figure 
3.1. Ashkin first demonstrated the trapping system using two counter propagating beams to 
form a dual beam trap in 1970 as depicted in figure 3.1A. Later on a stable single beam 
levitation trap (Figure 3.1B) was demonstrated when manipulating transparent dielectric 
particles of high refractive index [4]. 
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Figure 3.1 Optical trapping geometries: (A) A dual beam trap with lateral confinement controlled by counter-
propagating beams. (B) The levitation trap in which the beam intensity spreading provides lateral trapping to form 
a two dimensional trap in which the scattering force dominates. Presented in picture (C) is a single beam optical 
trap or a gradient force trap in which the optical gradient forces overcome the scattering forces resulting in a three 
dimensional trap [1, 4]. 
 
The earlier optical traps were dependent on laser radiation pressure force to stably hold spheres 
in the axial plane against gravity and the transverse gradient beam held them in the centre of 
the Gaussian beam. Figure 3.1C shows a trapping system achieved through a single tightly 
focused laser beam known as optical tweezer [1]. 
 
3.2 Forces governing optical traps 
3.2.1 Gradient and scattering forces in a three dimensional trap 
In optical trapping, when the small particles are exposed to the tightly focused laser beam they 
experience two types of forces namely gradient and scattering forces. The scattering force is a 
consequence of light having momentum and is produced by the photons as they come into 
contact with the particle. It acts in the beam propagation direction and is dependent on light 
intensity, the laser beam wavelength, the particle size and its refractive index contrast against 
the medium in which they are immersed.  
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On the other hand, the gradient force is the one that pushes towards the laser focus in the region 
of highest light intensity. It is linearly dependent on the spatial variation of the intensity of the 
light field and on the dielectric contrast of the particle relative to the surrounding media [6].  
 
 
Figure 3.2 Three optical trapping approaches based on the beam wavelength and particle size [7,8]. 
 
Based on the laser beam wavelength (λ) and the size of the particle (r) and forces involved, 
there are three proposed approaches as shown in Figure 3.2: one based on electric field 
associated with the light Rayleigh where the particle size is smaller than the wavelength (r < 
λ), the next one is based on ray optics for particles in the Mie regime in which the particle size 
is greater than the wavelength of the trapping beam (r > λ) and the last one based on 
electromagnetic field model for particles in the intermediate regime in which the particle size 
is almost equal to the beam wavelength in size (r ~ λ) [7, 8].  
 
3.2.2 Mie regime explained 
In this regime, the wavelength of the laser beam is smaller than the diameter of the trapped 
particle and it uses the Ray Optics approach or the conservation of momentum model [3].  
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The effect of a laser beam on a microscopic particle with a bigger diameter can be modelled 
with a bundle of rays, with each ray weighted according to its light intensity. A photon of 
wavelength λ has momentum:  
 
                                                                    𝒑 = 𝒉/𝝀                                                         (3.1) 
 
(or ħk) where h is Plank’s constant, ħ is h/2π, and k is wave number. When a particle causes 
light to change its direction through refraction or reflection, the change of momentum is 
experienced from individual light rays and an equal but opposite momentum change is 
generated. When using the ray optics approach, if a transparent microscopic particle is situated 
within a gradient of light, the refraction of rays of differing intensity (due to the gradient) 
through the particle results in a change in total momentum of the exiting laser beam and hence 
a corresponding reaction force on the particle, which draws the particle into the region of 
highest light intensity of the beam as depicted in Figure 3.3A. An equilibrium position is 
reached and the particle is held in the beam centre as the rays of light passing through and 
exiting the particle are balanced with no overall change in momentum of the beam.  
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Figure 3.3 The ray optics of the lateral and axial trapping force within optical tweezers. Shown in (A), when a 
bead with a refractive index higher than the surrounding medium is positioned to the left of the beam’s region of 
highest intensity; more rays get refracted from the right to the left as they go through the bead. The net force then 
transfers momentum towards the left and the particle encounters an equal but opposite force drawing it towards 
the beam centre. In (B), off axis rays lead to axial trapping as they get refracted in the direction of beam 
propagation and a force of equal size but opposite direction is exerted on the bead causing the change in the 
momentum of light [10, 11].  
 
This trapping force is due to the transverse gradient force which is a result of the Gaussian 
intensity distribution of the laser mode; however an axial gradient is also required in order to 
lift the particle and manipulate it in three dimensions [7, 9]. For axial trapping in the z (vertical 
plane) direction, off axis rays come in at an angle towards the particle and gain momentum in 
the beam propagation direction. This momentum change results in a force that pushes the 
particles upwards against the beam propagation direction towards the beam focal region, 
thereby generating a trapping force in the z-direction, hence the three dimensional trap. The 
point of equilibrium is obtained when the scattering force and gravity (both push the bead 
downward) is balanced by the axial gradient force (which pushes the bead in an upward 
direction) (Figure 3.3B). 
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3.2.3 Interaction of light with Rayleigh particles 
In this regime, particles are much smaller than the laser beam wavelength and therefore 
trapping them considers the force in terms of the electric field in the region of the trapped 
particles. When a polarisable particle is situated in the electric field it experiences an electric 
dipole moment as it responds to the electric field of the laser beam and is attracted to intensity 
gradients in the electric field towards the focus (if the refractive index is greater than 1). When 
the particle moves to where the electric field is highest (which is the focus), the energy of the 
system will be at a minimum [12].  
 
3.2.4 Trapping intermediate regime 
In this regime, the particle size is comparable to the trapping laser beam wavelength, and 
therefore neither the electric field approach nor the ray optics approach is suitable to determine 
the forces that are responsible for trapping. However, the electromagnetic theories are 
applicable for intermediate size range [13]. In this work both the beads and cells trapped lie in 
the Mie regime, since the laser beam wavelength used was 1064 nm and the beads used had a 
2 µm diameter and TZM-bl cells ranged anything between 12 and 25 µm in diameter. 
 
3.2.5 Optical trap efficiency 
The capability of the optical tweezing system to trap or hold particles of interest is determined 
by making use of the Q value method. This method works by measuring the velocity at which 
the particle escapes from the trap when it is dragged through the sample medium. It is obtained 
by translating the motorized sample stage which holds the sample chamber at a known velocity 
and calculating the velocity at which the particle escapes from the trap. With the stage motion 
controller the sample stage can be manoeuvred at a constant velocity.  
69 
 
The sample is usually a microscopic particle suspended in liquid and the sample chamber with 
a well is normally made up of a bottom coverslip and a top coverslip separated by a vinyl spacer 
(~100 μm depth, 12 mm in diameter). The well of the sample chamber is the vinyl spacer 
opening as illustrated in Figure 3.4. 
 
 
Figure 3.4 The figure shows the sample chamber made of two coverslips and a well where the sample is loaded 
in between the coverslips. 
 
The Stokes drag force (Fdrag) which is present during the dragging process is equal to the forces 
exerted on the particle (Ftrap). The dragging denotes the horizontal pulling of the particle 
through the sample chamber as depicted in Figure 3.5.  
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Figure 3.5 The drag force opposes the relative motion of a particle through a fluid, acting in the direction opposite 
to the oncoming flow velocity and depends on the velocity [14] 
 
The Stokes drag force determined by using equation 3.2: 
                                                                      𝑭𝒅𝒓𝒂𝒈 = 𝟔𝝅𝛈𝒗𝒓                                                       (3.2) 
 
where η is the fluid viscosity, r is the particle radius and v is the particle velocity with respect 
to the fluid [15]. 
 
The drag force varies with the particle dragging velocity and it is zero when the particles are 
stationary. This is the maximum force that can be exerted by the optical trap at a given laser 
power and it is usually in picoNewton order. The critical velocity for the particle escape from 
the trap scales linearly with laser power. The trapping efficiency of any optical tweezer 
configuration is usually described in terms of a dimensionless parameter Q, the fraction 
momentum transferred to the trapping force from the trapping laser beam, which is related to 
the force on the particle, Ftrap, the laser power P, c for the speed of light, and the surrounding 
medium refractive index nm through the equation: 
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                                                                   𝑭𝒕𝒓𝒂𝒑 = 𝑸
𝒏𝒎𝒅𝑷
𝒄
                                     …                    (3.3) 
 
Since the Stokes drag force is equal to the optical force exerted on the particle; 
 
                                                   𝑭𝒅𝒓𝒂𝒈 = 𝑭𝒕𝒓𝒂𝒑                                                        (3.4) 
therefore, 
 
                                              𝟔𝝅𝛈𝒗𝒄𝒓 =  𝑸
𝒏𝒎𝒅𝑷
𝒄
                                                       (3.5) 
and, 
 
                                             𝑸 =  
𝟔𝝅𝛈𝒗𝒄𝒓
𝒏𝒎𝑷
                                                            (3.6) 
 
According to Felgner et al 1995 reported that both the lateral and axial trapping efficiencies of 
microparticles are used to measure the force at which the particles are effectively trapped [16]. 
The Q values of the optical forces acting on small dielectric particles tend to be in the range of 
0.03 to 0.1 [17].  
 
3.2.6 Optical trapping via a Gaussian beam 
Optical trapping uses a highly focused (non-diverging) Gaussian beam to trap and manipulate 
microparticles. The most preferred lasers for optical traps are continuous wave lasers as pulsed 
lasers would damage specimens due to their high energy in space and time [18]. Construction 
of a home built optical trapping system can be achieved by using off the shelf optical 
components, as long as special emphasis is put on optical arrangement and alignment [19].  The 
arrangement of optical components must be done such that the beam is expanded, reflected and 
delivered to the back aperture of a microscope objective via sets of lenses and mirrors set on 
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the beam path. Furthermore, a laser wavelength and its quality must be considered, as well as 
other aspects as discussed below. 
 
The laser should deliver a single mode output (Gaussian TEM00 mode). The Gaussian beam 
irradiance is exponentially reduced towards the edges of the beam thereby providing the 
transverse optical gradient needed to trap particles in a three dimensional optical trap. In 
addition, a few essential properties that one should consider when selecting a good trapping 
laser include the laser wavelength and the M2 factor of the laser [20]. The laser beam quality 
is assessed by M2, which signifies how closely a beam matches the ideal Gaussian beam. The 
M2 value of a beam that matches a perfect Gaussian beam profile is 1, and such a beam would 
have no transverse aberration when focused to a diffracted limited spot [21]. A good-quality 
optical trap is achieved when the M2 of a laser beam focused with a high numerical aperture 
microscope objective is less than 1.1 [22].  
 
The chosen laser beam should have a wavelength that lies out of the absorption region of the 
trapped particle and the medium it is immersed in [18]. When the laser wavelength is close to 
the absorption band of the trapped particle, undesirable thermal effects are created. These 
undesirable effects have a potential to damage the trapped particle, thereby causing the 
destabilization of the trap [7]. Hence lasers within the infrared region (~750 to 1200 nm) of the 
electromagnetic spectrum are the most preferred when trapping biological materials as most 
cells display good transparency in this region [9]. Shorter wavelengths below 800 nm can cause 
damage to the cells as this is the region in which the majority of cellular molecules absorb light 
[23, 24, 25]. Water as one of the cellular molecules has a very complex absorption spectrum 
due to its various phases and transitions, which causes it to absorb light at different regions of 
the electromagnetic spectrum [26, 27].  
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In order to reduce the heating effects generated when using the usual water, heavy water (D2O) 
is used because it absorbs less within the infrared region [28]. In addition to water, cells also 
contain carbohydrates, nucleic acids and proteins, which also have their various light absorbing 
characteristics [29].  
 
A stable three dimensional trapping is established when the gradient force is greater than the 
scattering force [7]. It is attained by using a high numerical aperture (NA ≥ 1.2) microscope 
objective, which produces steep gradients due to the angle which the off axis rays come into 
the sample [9]. The numerical aperture is a dimensionless value that represents the ability of 
the microscope objective to gather light and defines the smallest region that light can be focused 
at its focal point. It is defined by NA = nsin θ, where n is the refractive of index of the medium 
and θ is the half angle of the cone of light that enters or leaves the microscope objective. The 
use of infinity corrected microscope objectives is common in the construction of optical 
trapping systems, as they offer the highest flexibility.  
 
Furthermore, a good quality optical trapping system is produced by overfilling the back 
aperture of the microscope objective with a laser beam, so as to obtain a diffracted limited spot 
and also generate a considerable gradient in the focused beam [20]. The overfilling of the back 
aperture is gained by expanding and collimating the laser beam with a telescope. Before the 
beam enters the back aperture of the microscope objective, it goes through a simple 1:1 
telescope arrangement (beam steering) in order to allow conjugate images to be formed 
between the beam steering mirror and the back focal plane of the microscope objective. The 
beam steering ensures that the beam does not travel off its position. During the steering, the 
beam overfilling the back aperture needs to be centred upon the back aperture [30].  
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By means of a dichroic mirror placed at 45º, the beam is directed into the microscope objective, 
but allows white light from the Koehler illumination to pass through and an image is formed 
on the camera which can be viewed on the monitor. 
 
3.2.7 Gaussian beam propagation 
Gaussian beams have single maximum centred along the beam propagation direction and 
diverging at an angle away from beam waist w0. The diverging angle θ can be described by 
equation 3.7 [31].  
                                                     𝜽 =
𝝀
𝝅𝒘𝟎
                                                     (3.7) 
where λ is the wavelength of the laser light. The Rayleigh length (ZR) of a laser beam as 
described by the following equation,  
                                                       𝒁𝑹 =
𝝅𝒘𝟎
𝟐
𝝀
                                              (3.8) 
is the distance along the beam propagation direction (z axis) where the cross section of the 
beam waist is doubled as illustrated in Figure 3.6 [32].  
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Figure 3.6 The Rayleigh length ZR of a Gaussian beam and the beam waist w0 are shown. The Gaussian beam 
width w(z) is set as a function of the axial distance, with b being the depth of beam focus and as the total angular 
spread [33]. 
 
The beam divergence as described in equation 3.7 shows that the smaller the radius of the waist 
and the longer the wavelength, the sturdier is the beam divergence from the waist [34]. In its 
propagation the Gaussian beam keeps the Gaussian intensity profile along its entire beam axis; 
with only a variation in the beam radius. In addition, Gaussian beams stay Gaussian even after 
passing simple optical elements such a lenses and mirrors with no aberrations [35]. 
 
3.3 Typical optical trapping setup 
3.3.1 Assembling an optical trapping system  
The MIL-S-1064 nm diode laser with a beam spot of 1 mm was used in this work. Since the 
back aperture of the microscope objective used was 8 mm, the beam size had to be magnified 
to slightly overfill it. The beam size was expanded with a simple two bi-convex lens telescope 
L1 and L2 (f = 25.4 mm and f = 300 mm respectively) to ~8.3 mm. The newly expanded beam 
was directed to the microscope objective through the beam path by being reflected with mirrors 
M1 and M2 in Figure 3.7.  
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Figure 3.7 A presentation of a basic optical trapping system constructed using a 1064 nm diode laser with 
maximum output power of 1.5 W. This setup is useful for biological trapping as it consists of an infrared laser. 
 
Mirror M2 then reflected the beam to the 1:1 telescope arrangement for the steering of the beam 
at the back aperture of the microscope objective. The beam steering comprised of two identical 
plano-convex lenses, L3 and L4 (f = 100 mm each), which were separated by the sum of their 
focal lengths, so that the incident parallel beam produces a parallel output of the same beam 
diameter [17]. The flat surfaces of the lenses face each other; as such the spherical aberration 
is minimized [36]. A dichroic mirror positioned at 45° was placed after L4 to reflect the laser 
beam into the 100X oil immersion microscope objective with a high numerical aperture of 1.25, 
but also to allow the white light from the Koehler illumination to pass through for the formation 
of the image on the charge coupled device (CCD) camera which can be viewed on a computer 
monitor.  
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The 100X objective focused the laser beam to a 1.08 µm diffraction limited spot. The white 
light was directed to the CCD camera by M3 and reduced using lens L5 in order to fill the 
detection area in the camera. The xyz translation stage on which the sample was placed was 
situated just above the microscope objective. By translating the stage, the sample could be 
moved to different directions. Above the sample stage was a Koehler illumination setup which 
provided an even illumination across the sample. 
 
3.3.2 Optical trapping of microspheres and TZM-bl cells 
Having built and aligned the setup illustrated in Figure 3.7, its efficiency was assessed by 
trapping 2 μm polystyrene microspheres. The spheres were successfully trapped using 97 mW 
laser power output on the sample stage as shown in Figure 3.8.  
 
 
Figure 3.8 Pictures from a CCD camera displaying the trapping of 2 μm polystyrene beads using the optical 
trapping system illustrated in Figure 3.7 at 97 mW. The particles are trapped by the laser, and the beam position 
on the slide is depicted by the white circle. The images were taken at different time points after the sample (slide 
containing beads suspended in detrium oxide) was exposed to the beam on the trapping system (A) After 45 
seconds (s), (B) 47s, (C) 50s, (D) 53s and (E) 56s. 
 
In Figure 3.8 the spot where the beam is focused is shown by a white circle, with Figure 3.8A 
illustrating an already trapped bead and four nearby beads that are not yet trapped, but floating 
in solution. In Figure 3.8B; at 47 seconds one of the beads that were floating in A has been 
trapped, and the same is observed in C and D as the clump (highlighted by a white circle) of 
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beads grew. Figure 3.8E shows that more beads had been trapped including the ones that were 
floating in Figure 3.8A. 
 
Following the successful trapping of microspheres, the optical trapping system was further 
assessed in order to determine its capacity to trap cells. TZM-bl cells were trapped after 
exposing them to the laser beam on the sample stage of the same trapping system. The TZM-
bl cells were used as they are a cell line widely used in HIV-1 related research studies, mainly 
the ones looking into finding HIV treatment. This cell line has CD4 and CCR5 molecules on 
the cell surface to enable HIV-1 entry. Since they are permissive to HIV-1 infection, they were 
used in the current study instead of using blood samples that would require human study 
participants. TZM-bl cells are 25 μm in size and 12 times bigger than the polystyrene beads 
trapped in Figure 3.8. The trapping of the cells was observed from 47 mW with a weak trap 
that falls out at the slightest move (40 μm/s) of the sample stage. However, as the power 
increases the trap becomes more stable, with 185 mW being the maximum power of the laser 
on the sample stage. After trapping the cell at 185 mW average power the sample stage was 
moved to different directions, in order to assess and determine the conditions that would cause 
the cell to fall out of the trap. Figure 3.9 shows a trapped cell at 155 mW with the sample stage 
moving at 160 μm/s to the right. 
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Figure 3.9 Pictures from a CCD camera displaying the trapping of TZM-bl cells using the optical trapping system 
illustrated in Figure 3.7. The sample stage is moved towards the right and the untrapped cells (such as cell A and 
B) also flow to the right, while the trapped cell remains unmoved. At different time points it is visible that the 
untrapped are shifting from their original positions as indicated by the red arrows. 
 
Once the cell was trapped and the stage moved, the trapped cell remained at the same spot 
while the nearby cells moved across it as shown at the different time points of Figure 3.9. In 
Figure 3.9, at 2 and 3 seconds, cells A and B are moving towards the right in the direction of 
the trapped. At 4 seconds cell B is passing behind the trapped cell and at 5 seconds cell B has 
partially gone past the trapped cell while cell A is still passing the trapped one. At 6 seconds 
cell B has far gone past the trapped cell. At 7 seconds cell B has gone past area visible to the 
camera and cell B is about to disappear too. Being able to trap the TZM-bl cells led to the next 
step of trapping both HIV-1 infected and uninfected in order to examine them and differentiate 
between HIV-1 infected and uninfected cells using transmission spectroscopy, which would be 
discussed in the next section. 
 
3.4 Detection of HIV-1 infection in TZM-bl cells using optical trapping in conjunction 
with transmission spectroscopy 
3.4.1 Transmission spectroscopy overview 
The interaction of light with matter can result into light being transmitted, absorbed or 
reflected. Since this section deals with transmission spectroscopy, the focus will be on the 
transmission of light instead of the other mechanisms that occur as a result of light and matter 
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interaction. Transmission of light occurs when electromagnetic radiation passes through a 
material without being absorbed and therefore the transmittance of any given material is the 
amount of the incident light that travels all the way through to the other side of a particular 
barrier. This then implies that transmission spectroscopy is the measurement (analysis) of the 
emission of energy as electromagnetic radiation as a function of wavelength that has been 
passed through a sample [37]. It is a non-invasive and real time optical detection technique that 
has found wide applications in pharmaceutical industry as well as in biological and medical 
fields [38, 39, 40, 41, 42]. This technique’s detection ability is based on distinguishing samples 
based on size, shape and sample concentration, it is highly sensitive with pico-molecular ranges 
detection limits [42].  
 
Transmission spectroscopy has been successfully used for the diagnosis of dengue viral 
infection. According to Firdous et al 2012 it was done by recording transmission spectra of 
both the dengue infected blood samples and the uninfected ones [43]. The infected blood 
spectra showed a band with a more convincing band from 400 to 600 nm [43]. Dengue viral 
infection may be diagnosed by processes such as nucleic acid detection by polymerase chain 
reaction (PCR), virus isolation in cell cultures and virus specific antibodies. However, the latter 
two techniques are the most sensitive, but they are not routinely used due to high costs 
associated with them. Therefore, the availability of a fast screening, cost effective and easy to 
use method could reduce the cost related burden in the diagnosis of dengue fever [43].  
 
In another study conducted by Mahon et al 2013 transmission spectroscopy was used in marine 
ecosystems and freshwater for the detection of invasive species with adverse impact on the 
economy and biodiversity.  
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It was used for the early detection of undesirable species for effective biocontrol to alleviate 
possible ecological and economical destruction [44]. They tested to check if transmission 
spectroscopy would be able to detect the presence of the invading species within a sample with 
mixed species, they also investigated if concentration of the target species could be determined 
and tested for differences between amplified DNA and unamplified. In the study they were 
able to screen samples obtained directly from nature (with no modification) without the 
necessity for prior PCR amplification. Due to its user friendliness and short detection times, 
transmission spectroscopy is an attractive technique in environmental monitoring studies where 
it can easily be taken and used at the point of sample collection without getting to the 
laboratory. This makes it a useful tool for field application [44].  
 
Literature has shown that near infrared transmission spectroscopy technique can allow the 
determination of the mean paracetamol content of intact tablets by looking at the spectra pattern 
[38]. In addition, transmission spectroscopy is often applied to determine the tissue properties. 
It has been used to quantify for instance tissue chromophore concentration [39]. Furthermore, 
the analysis of transmission spectra patterns has led to the differentiation of red from white 
human blood cells, as well as cancerous from non-cancerous cell species and the investigation 
of the influence of wavelength on red blood cell aggregation [41, 42, 45]. However, when 
examining the experimental makeup of the transmission spectroscopy, there are some 
parameters that affect recorded spectra. These parameters include sample thickness and sample 
unevenness that causes severe loss of the transmitted signal; therefore during sample 
preparation care must be taken on sample thickness and homogeneity [38, 42]. The 
transmission measurements are often done on immobilized cells using substrate or aqueous 
cells suspension.  
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In both cases samples are not uniformly distributed, therefore unevenness would generate 
spectral artefacts [41]. These artefacts generally alter the peak intensity that cause false 
interpretation of results obtained [39]. 
 
The coupling of transmission spectroscopy with optical trapping provides an attractive method 
that allows for the manipulation of single cells instead of only focusing on cells in suspension 
or a layer of cells that might be uneven. In essence, optical trapping helps to overcome the 
limitation imposed by transmission spectroscopy of the ensemble measurement and sample 
thickness [46]. 
 
3.4.2 Coupling of the optical trapping system with transmission spectroscopy 
The trapping system demonstrated in Figure 3.7 was slightly modified by integrating the 
transmission detection system and the newly formed trapping/transmission system is exhibited 
in Figure 3.10. The laser beam was used for both optical trapping and laser transmission 
spectroscopy. A long working distance objective (distance focal of 200 mm) was utilized to 
collect the transmitted laser light from the sample and also coupled the Koehler illumination to 
the sample plane. The collected transmitted laser beam was focused into a single mode fibre 
by a 40 mm distance focal lens in order to guide the light onto the entrance slit of the Andor 
spectrometer (Shamrock 303i) and the transmittance spectra were detected by the Andor iStar 
734 series CCD camera. The iStar camera was air cooled to -200ºC in order to reduce the effect 
of dark current, which increases the amount of fixed pattern noise [47]. The image trapped cells 
were viewed through video camera (Watec, W96N15832 CCD camera) illuminated by the 
Koehler illumination system.   
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Figure 3.10 Optical trapping coupled to the transmission spectroscopy experimental system used to determine the 
transmittance spectra of TZM-bl infected and uninfected single cells. L1-L6 refers to lenses used, M1-M2 are the 
infrared mirrors, M3 is the highly reflective silver mirror and DM is the dichroic mirror. 
 
3.4.3 Optical trapping and transmission spectroscopy measurements on HIV-1 infected 
TZM-bl cells 
In two separate 35 mm glass bottom petri dishes 500 µl suspension of infected and uninfected 
cells were added and these samples were covered with glass coverslips prior to observation on 
the optical setup. For the purpose of transmittance experiments, background subtractions and 
normalization were first conducted by subtracting the background light from the signal and 
have a laser intensity reference and thereafter the samples were analyzed. The transmission 
spectra of HIV-1 infected and uninfected TZM-bl cells were captured using the Andor solis 
software. The intensity of transmission was expressed in terms of photon count which is a 
number of light photons transmitted through a trapped cell.  
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Preceding the optical trapping transmission experiment, the background and reference 
intensities were recorded and Figure 3.11 outlines how the procedure was performed.  
 
 
Figure 3.11 A schematic representation of a procedure used to record the background, reference 
and transmitted signal. 
 
The intensity background was acquired by recording a dark signal when the laser was off and the petri 
dish was empty. On the other hand, the reference intensity was captured with laser on and an empty petri 
dish. However, the sample signal was measured with laser on and petri dish containing TZM-bl cells in 
suspension, with one cell trapped. In data processing, the transmission spectra are shown in 
transmittance percentage given by the following equation: 
                                        
TI (%) = 100 ∗ 




 
0I
II BS                    (3.9) 
 
With IT being the transmittance percentage intensity, IS the signal intensity, IB background 
intensity, I0 reference intensity. It is worth noting that the reference intensity is the background 
corrected incident intensity.  
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The initial form of transmission investigation done was to study the influence of the virus on 
the transmittance intensity signal by measuring the transmittance intensity of media only and 
then the media with virus (media and virus on Figure 3.12). Figure 3.12 shows transmittance 
intensity of cell growth media only and that of media with virus. The two transmission spectra 
appear relatively similar with a transmittance percentage of 20%.  
 
 
Figure 3.12 Transmission spectra of cell growth media (black) and pseudo-virus & media (red) recorded between 
9425 cm-1 and 9375 cm-1. 
 
For each trapped cell 50 signal spectra were recorded and an averaged spectrum was calculated 
and automatically distributed from the Andor solis software. The exposure time to capture each 
spectrum was 3.4 seconds, making the total average acquisition time for 50 spectra 3 minutes 
as shown in Figure 3.13. The final spectrum obtained was exported into Origin-Pro 8 for data 
analysis.  The transmission spectra of both uninfected and infected cells have peaks at 9398 
cm-1 even though they show slight variation in the peak amplitude as depicted by the 
transmittance percentage. 
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Figure 3.13 Transmission spectra for individually trapped HIV-1 infected and uninfected cells suspended in cell 
growth media in the region from 9420 cm-1 to 9350 cm-1. Each spectrum represents the average of 50 spectra of 
trapped cells. The inserted pictures show trapped uninfected and HIV-1infected TZM-bl cells with HIV infected 
(indicated by a blue line) cells appearing more granular than uninfected cells (indicated by a black line). 
 
To confirm consistency and reproducibility, the measurements were repeated on ten infected 
and uninfected cells. Figure 3.14 shows the transmittance peak intensities of HIV-1 infected 
(in red) and uninfected (in black) TZM-bl cells. The overall average of the ten transmittance 
intensity percentages for HIV-1 infected and uninfected was found to be 15.95±0.79 and 
19.73±0.98, respectively. The results revealed that transmittance percentage of uninfected 
TZM-bl trapped cells remain greater than the one for HIV-1 infected trapped cells. 
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Figure 3.14 Transmittance spectra peaks values of 10 infected cells compared to those of 10 uninfected cells. 
 
In addition to transmittance percentages data of HIV-1 infected and uninfected cells, areas 
under their spectral peaks were integrated.  
 
Table 3.1: Values of area under the spectral peaks of ten HIV-1 infected and uninfected TZM-bl cells in nm2 
Cell 1 2 3 4 5 6 7 8 9 10 
Uninfected  69.76 71.44 72.23 73.55 70.67 70.50 71.64 71.73 70.83 69.94 
Infected  64.50 67.35 66.89 67.35 68.53 69.10 69.19 68.90 68.20 67.14 
   
The values of the areas beneath the graphs attained for ten cells are presented in table 3.1. The 
results show that areas under the spectral peaks of infected cells are less than those of 
uninfected cells. These findings confirm the trend seen in the transmittance percentages data.  
 
3.5 Discussion 
In this study optical trapping was used to hold both microspheres and cells; with the intention 
of analysing cells so as to differentiate between HIV-1 infected and uninfected TZM-bl cells 
using transmission spectroscopy. As shown in Figure 3.8 and 3.9 the 1064 nm laser used 
successfully trapped both the microspheres and the cells.  
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Both cells and microspheres have diameters greater than the wavelength of the trapping beam 
and they both used the ray optics trapping approach as outlined in Figure 3.3. However, it was 
easier to trap microspheres than cells, so much that when trapping microspheres clumps (Figure 
3.8) were formed as many microspheres were drawn to the beam centre and this was not 
observed when trapping cells (Figure 3.9). The differences in trapping microspheres and the 
cells could be primarily attributed to the differences in sizes. The cells were 25 μm in diameter 
while the microspheres were only 2 μm. Since the beam centre has the highest intensity 
compared to the edges, it was easier to tightly trap smaller particles even into clumps than 
holding 25 μm cells. In addition to the differences in sizes, the polystyrene beads had a higher 
refractive index of 1.5 compared to the cells with a refractive index of 1.37 [48, 49].  
 
In trapping, particles with higher refractive index are easier to trap compared to those of lower 
refractive index [2]. During the trapping experiments, it was also observed that a tight trap in 
cells occurs at higher powers compared to microspheres as reported in Figures 3.8 and 3.9, 
where powers of 97 mW and 155 mW were used for microspheres and cells respectively. In 
the system used the minimum power at which the laser’s trapping abilities were observed was 
30 mW for microspheres, but 47 mW for cells. At these low powers the particles would be 
pulled towards the beam centre even though it would not last for long or when the stage is 
moved the particle would leave the trap. In some instances, the particle would just leave the 
trap when another particle in Brownian motion comes into contact with the trapped particle.  
After coupling the trapping system with transmission spectroscopy and assessing the 
transmission patterns of the background, reference and the sample as shown in Figure 3.11, 
transmittance intensities between the plain media and the media containing the virus were 
measured (Figure 3.12). There were similarities in transmittance intensities and these 
similarities were not alarming because pseudo-viruses are generally stored in growth medium. 
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Pseudo-viruses are produced using HEK293T cells and at harvest the medium in which the 
virus is contained is filtered to remove any traces of cells that could be in the medium and the 
filtered medium (the pseudo-virus) is stored at -80°C. During cell infection with a pseudo-
virus, a small volume of the medium containing the virus is added to cells, hence there are no 
significant differences in the spectra measurements obtained when assessing transmittance 
intensities of media only and that of media with virus as demonstrated in Figure 3.12. 
Transmission spectra are strongly influenced by the biochemical composition of a sample, its 
homogeneity and sample thickness [39-41].  
 
The absence of differences between the media only and the media with virus samples was an 
indication that the virus in cell growth media does not influence the transmission 
measurements. These results correlate well with what was previously reported that differences 
between two different samples can be detected by even a slight difference in the intensity; 
especially if the samples are very similar or highly related [41, 42]. Infected and uninfected 
TZM-bl cells present a transmittance peak intensity percentage around 16.77% and 18.80 %, 
respectively. These differences in transmittance spectrum are attributed to parameters such as 
sample thickness, cell consistency, refractive index and sample thickness (path length of the 
light). Seeing that cells in suspension are approximately spherical, the path length of the near 
infrared light in the cell will be equal to the diameter of the cell.  
 
The Zeiss axiocam (ERc 5s) CCD camera combined with the Olympus CKX41 microscope 
(with 60X objective lens) were used to estimate the average diameter of the HIV-1 infected 
and uninfected cells by measuring cell sizes and calculating the average diameter. The average 
diameters obtained for HIV-1 infected and uninfected was 17.04 ±1.10 µm and 18.77±2.39 
µm, respectively.  
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This transmittance percentage difference observed could be hypothetically attributed to the 
differences in refractive index of the two cell groups. The cell images in Figure 3.13 show 
visible morphological differences between infected and uninfected cells, with the infected cells 
showing granularity. Numerous lines of evidence show that HIV-1 infection can generate a 
wide range of reactions in the host cell, hence the granularity in infected cells [50-52]. These 
reactions include the processing of viral protein into peptides molecules that change the 
biochemical composition of cells. As a result, the scattering coefficient will be altered due to 
change in the refractive index. It has been reported that light experiences deflection because of 
the internal cellular structures (organelles) [53]. The granularity and potential light scattering 
in the HIV-1 infected could be the second factor that induced low transmission of the near 
infrared light. This study demonstrated the great potential that optical trapping has in disease 
diagnosis when coupled with spectroscopy for analysis. 
 
These findings have been encouraging, as such other spectroscopy techniques with more 
specificity such as Raman spectroscopy will be used to further analyze the trapped cells so as 
to pinpoint the differences between HIV-1 infected and uninfected cells. Additionally, super 
resolution imaging techniques will be coupled to the trapping system in order to visually 
observe the molecular differences between infected and uninfected cells.  
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Chapter 4 
 
Label-free detection of HIV-1 infection in TZM-bl cells using luminescence 
spectroscopy 
 
Introduction 
In chapter 3 the focus was on optical trapping and transmission spectroscopy measurements 
for HIV-1 infected and uninfected cells, summarising the history, mechanisms and applications 
thereof, in medical and biological research. The current chapter focuses on luminescence based 
label-free detection of HIV-1 infection in TZM-bl cells. The first section gives an overview on 
luminescence and how it occurs through absorption and emission of radiation, as well as a 
detailed description on how bioluminescence takes place and its applications. This is followed 
by a detailed overview on luminescence spectroscopy and the major components of such 
systems. Also, both the quantitative and qualitative analysis of samples using luminescence 
based techniques is reviewed. Next, the use of luminescence spectroscopy is demonstrated for 
the first time in the detection of HIV-1 infection in TZM-bl cells. Finally, the findings of the 
study are discussed. 
 
4.1 Luminescence mechanisms 
4.1.1 General introduction on luminescence 
Luminescence is the emission of electromagnetic radiation (light) by a substance following the 
absorption of energy [1].  
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This emission takes place when the materials emitting light are reasonably cold, unlike light 
emitted from incandescent figures such as burning coal, metal iron and electric current heated 
wire. Therefore, luminescence is an umbrella term that includes all forms of light emission that 
are not a consequence of high temperatures. Luminescent substances are known as phosphors 
and have wide applications in TV screens, modern LEDs, cell phone screens, biological 
imaging, emergency route signage, etc. Luminescence is also seen in organic substances such 
as luminols or the luciferins in fireflies and glow worms as well as in some pigments used in 
outdoor advertising. The real value of phosphors lies in their capacity to transform invisible 
forms of energy into visible light [2]. Luminescence can be categorized according to the energy 
used to excite the phosphor and produce light (luminescence) and the classes are: 
photoluminescence which occurs when excitation is by a photon (normally uses UV radiation), 
chemi-luminescence occurs when the material is excited by the energy of chemical reaction, 
cathode-luminescence is due to excitation by means of energetic electrons, 
electroluminescence is due to excitation by an electric voltage and triboluminescence is 
produced by mechanical energy such as grinding [3]. The focus of the current study is bio-
luminescence as the luminescence is produced due to the reaction that takes place between the 
luciferase enzyme expressed by the TZM-bl cells after HIV-1 infection had taken place. The 
cellular luciferase enzyme then reacts with the luciferase reagent added to the infected cells 48 
hours post infection. 
 
4.1.2 Absorption and production of luminescence 
In general, luminescence covers two processes, which are absorption or excitation and 
emission. During absorption a photon of energy passes some of its energy to excite electrons 
from low energy levels to higher energy levels.  
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The absorption of energy leading to luminescence takes place by either the host lattice (as 
shown in Figure 4.1) or by intentionally doped impurities. The emission usually happens on 
the impurity ions which are called activator ions when they generate the desired emission. 
When the activator ions show weak absorption, a second impurity ion called the sensitizer is 
added, which absorbs the energy and then transfer the energy to the activators. So, in the host 
lattice, the activator becomes excited by the absorbed energy; the electron on it absorbs the 
energy and is raised to an excited state.  
 
 
Figure 4.1 Schematic representation illustrating (a) direct excitation of the activator and (b) indirect excitation 
followed by energy transfer from the sensitizer or host to the activator [4]. 
 
The excited state then returns to the ground state by photon emission [3]. The observed 
emission from a luminescent centre is a process of returning to the ground state radioactively. 
Competing with luminescence are non-radiative processes, and in order to design an efficient 
phosphor, the non-radiative process must be suppressed.  
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The basic luminescence mechanism is demonstrated in Figure 4.1. Excitation by absorbance of 
some form of energy leads to two technically important classes of luminescent species, which 
are fluorescence and phosphorescence. Their production is illustrated in Figure 4.2. These two 
terms are based on both the persistence of luminescence and the way in which the luminescence 
is produced. When an electron is excited to a singlet state with a lifetime of nanoseconds, it 
then returns to its ground state emitting a photon in the form of fluorescence. On the other 
hand, an electron may be lifted to a higher energy state known as the excited triplet state. For 
quantum mechanical reasons, transitions from triplet states to singlet states are forbidden, 
thereby causing the lifetime of triplet states to be considerably longer than the singlet ones.  
 
 
Figure 4.2 Energy diagram showing absorption of light and the processes involved in the emission of light as 
fluorescence and phosphorescence [5].  
 
Therefore, luminescence from triplet energy states has longer duration than those originating 
from the singlet states and phosphorescence is observed [4].  
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In this study we observed bioluminescence in the form of phosphorescence as the luminescence 
stayed for a longer period and this was observed in the decay curve as shown later in the chapter 
(Figure 4.7C). 
 
4.1.3 Bioluminescence 
The emission of light by living organisms or laboratory biochemical systems developed from 
organisms is known as bioluminescence. It occurs occasionally in a broad range of organisms 
such as bacteria and fungi, insects, fish and marine invertebrates. However, there is no 
knowledge of its natural existence in mammals, birds, plants amphibians and reptiles. 
Bioluminescence is as a result of a chemical reaction (chemi-luminescence) whereby the 
conversion of chemical energy to radiant energy produces very little heat to no heat at all, hence 
the process is also referred to as cold light [6,7]. In the majority of bioluminescent organisms, 
the essential light-emitting elements are the oxidizable organic molecules luciferin and the 
enzyme luciferase. The luciferin-luciferase reaction is an enzyme-substrate reaction in which 
luciferin the substrate is oxidized by molecular oxygen and the reaction is catalyzed by the 
enzyme luciferase, resulting to light emission as summarized in Figure 4.3. The emission of 
light goes on until all the luciferin is completely oxidized. 
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Figure 4.3 Mechanism of luciferin bioluminescence: In phase 1, luciferin reacts with oxygen under ATP 
consumption, Mg2+ assistance and luciferase catalysis to yield a reactive, highly unstable intermediate Int1. This 
intermediate is decomposing in the second stage into carbon dioxide and intermediate Int2 in excited state (Phase 
2). Int2 undergoes de-excitation by emission of a photon with a characteristic wavelength (Phase 3). In case of 
luciferin, the emission maximum is at 550-570 nm [6]. 
 
Unlike with photoluminescence whereby a shorter wavelength excites the molecule and then 
emit at a longer wavelength, in bioluminescence emission is due to a reaction that takes place 
within a biological system. In firefly luminescence, which is what the current study is focusing 
on, adenosine triphosphate (ATP) primarily reacts with firefly luciferase, ionic magnesium, 
and firefly luciferin to form a complex (luciferase-luciferyl-adenylate) and pyrophosphate. The 
complex then reacts with molecular oxygen to emit light. Sufficient energy is liberated in the 
last step to transform the electronic configuration of the luciferase-luciferyl-adenylate complex 
from the ground state to excited state. The high-energy complex then misplaces energy by 
radiating a photon of visible light and goes back to the ground state [7]. Generally, 
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bioluminescence and chemi-luminescence based techniques are extensively used in biology 
and biochemistry such as in the detection of low ATP concentrations using bioluminescence 
as ATP is required for luciferin oxidation [7].  
 
Developments in the field of molecular biology have presented biotechnological means that 
make use of low background signal, detectability and swiftness of these luminescence based 
systems. They offer a great platform to in vitro and in vivo constant monitoring of biological 
processes such as disease progression, interaction of proteins and gene expression, as well drug 
discovery, diagnostic and clinical applications. The combination of luminescent enzymes with 
specific recognition features has given rise to the existence of selective and sensitive tools such 
as nucleic acid hybridization assays, immunoassays, microscopy or imaging and recombinant 
whole-cell biosensors. The popularity of these luminescence based analytical techniques has 
been intensified by their high detectability, which also makes them suitable for use in 
miniaturized analytical tools such as high density well microtiter plates, microarrays and 
microfluidic devices for the screening of proteins and genes in small sample sizes [4]. 
Bioluminescence has been applied in various immunoassays for either direct marking of 
antibodies and antigens with luminescent molecules or labeling with enzymes detectable 
luminescent substrates. Luminescent based reactions have gained much popularity due to their 
sensitivity for measuring enzyme labels [8]. Bioluminescence immunoassays resulted from 
using photo-proteins such as recombinant aequorin or a firefly luciferase coding DNA 
fragments as tags [9, 10]. Luminescence based assays have an influence on all forms of DNA 
diagnostic methods. The detection of viral DNAs is commonly achieved by using gene probe 
hybridization assays in combination with digoxigenin-anti-digoxigenin and biotin-streptavidin 
tagging systems.  
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Multiplex PCR methods can achieve detection limits in the range of 1-10 femtograms of DNA 
and they have been used in the detection of various diseases causing agents in urine specimens 
[11]. The value of bioluminescent based techniques was demonstrated in a study where it was 
compared to magnetic resonance imaging to confirm the therapeutic effect of 1,3-bis(2-
chloroethyl)-1-nitrosourea (BCNU) treatment in orthotopic rat brain tumors. These tumors 
resulted from 9L gliosarcoma cells genetically engineered to stably express firefly luciferase. 
The bioluminescence imaging results obtained were similar to those of magnetic resonance 
imaging, proving that it can also be effectively used in monitoring therapeutic effects of various 
compounds in living organisms [12]. According to Rehemtulla et al 2002, bioluminescence can 
be employed to assess the potential of therapeutic compounds for various diseases [12]. In 
another study conducted by Bernau human neural progenitor cells (stem cells) expressing 
luciferase were introduced into a rat in order to track these cells in vivo [13]. The cells were 
successfully tracked in the rat striatum for up to 12 weeks using bioluminescence imaging. This 
outcome was an indication that stem cells have a great potential in the development of cell 
based treatment for neurodegenerative disorders [13]. Bioluminescent labelled microRNAs 
have been employed for the detection of cancer.  
 
MicroRNA, miR21 was used as it is found in high levels in various cancers such as those of 
breast, liver, ovarian, pancreatic and brain when assessed with corresponding normal tissues. 
The luciferase labelled miR21 expression levels were high in human breast adenocarcinoma 
MCF-7 cancer cells compared to non-tumorogenic MCF-10A cells. The detection of miR21 
was enabled by using the bioluminescence based hybridization assay [14]. This section 
summarized various bioluminescence based techniques used in the field of biological and 
medical sciences. However, since this chapter is focusing on the use of luminescence 
spectroscopy, the next section will give an overview on luminescence spectroscopy. 
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4.2 Overview of luminescence spectroscopy 
4.2.1 Principles of luminescence spectroscopy 
As it has already been alluded to in section 4.1.2, luminescence or emission of light is a 
consequence of the interaction of light with matter. Emission is therefore a response to some 
form of acquired energy. This input energy causes molecules to get excited. As stated by 
quantum mechanics, molecules are permitted to be in certain distinct forms with definite 
amounts of internal energy (the quantum mechanically permitted states). A molecule can alter 
its state in between legitimate states if the difference in the energy between the two states is 
provided by an external source. In addition, the interaction of light with molecules can be 
divided into contributions equivalent to nuclear vibrational and rotational motion, electron 
transitions and spin interactions. Nonetheless, for luminescence spectroscopy, the occurrence 
of absorption and emission can easily be defined in terms of transitions of electrons between 
defined states [15, 16]. This transition between two molecular states can be seen as a switch of 
an electron from one molecular orbital to another. An excited molecule is rapidly reduced to 
the lowest vibrational level of the excited electronic state, which occurs in the time range of 
femto seconds to pico seconds.  
 
Luminescence arises as a result of decay from higher energy state to a permissible vibrational 
level in the electronic lower state as displayed in Figure 4.2 [4, 16]. Therefore, luminescence 
spectroscopy is the measurement of the manner in which molecules or systems emit radiation. 
Spectroscopic records are often denoted by an emission spectrum, a plot of the response of 
interest as a function of wavelength [17]. The emission spectrum is the emitted light comprising 
of phosphorescence, delayed fluorescence and fluorescence thus yielding three types of 
emission spectra.  
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Figure 4.4 shows absorption, excitation and emission spectra of a typical flourophore, as the 
fluorescence emission spectrum indicates almost mirror-like symmetry with its absorption 
spectrum. 
 
 
Figure 4.4: Absorption, excitation and emission spectra of a typical molecule [16]. 
 
The fluorescence is spectrally the same as the delayed fluorescence, on the other hand the 
phosphorescence spectrum while similar in shape is red shifted as a whole. The 
unconventionality of the shape of the fluorescence emission spectrum from the wavelength of 
the exciting light stems from the fact that emission always occurs from the lowest excited. If 
the shape of the emission spectrum is altered with changing wavelengths of the exciting light, 
then the existence of more than one fluorescent compound should be considered [16]. 
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4.2.2 Essential elements in luminescence spectroscopy systems 
A typical luminescence spectroscopy system needs a radiation source for excitation, a 
monochromator to choose the required wavelength for excitation, a sample holder, a detector 
a signal output display where the measurement is displayed (normally a computer screen) [18]. 
In the majority of commercial devices, the emitted radiation is generally detected at right angles 
to the incident beam; as such configuration presents the lowest background from incident light. 
Figure 4.5 below, illustrates the essential components of a spectrometer, moreover, frontal and 
straight through geometries are also employed mainly in instruments used to read microplates 
[16, 18].  
 
 
Figure 4.5 A schematic representation of essential elements in a spectroscopy system. The light source supplies 
radiation which goes through the monochromator for the selection of a single wavelength. The light then goes 
through the sample and the emitted light is transmitted and strikes the detector. The amount of emitted light is 
displayed through a luminescence spectrum [16,18]. 
 
Radiation sources for excitation include arc lamps for example xenon, tungsten, halogen, 
hydrogen, mercury deuterium lasers and synchrotrons. The light from the lamp is collected by 
an elliptical mirror and focused to the entrance slit of the monochromator. Then, the gratings 
in the monochromator can disperse radiation from 200 to 900 nm. On the other hand, entrance 
and exit slits of the monochromator regulate both the light intensity and wavelength spread. 
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Both the excitation and emission slit widths should generally be the same. The excitation 
monochromator selectively provides a narrow band of wavelengths of excitation that hit the 
sample. A fraction of the incident light is taken up by the sample, and some of the molecules 
in the sample fluoresce. There is no flawless monochromator; therefore some stray light (light 
with other wavelength other than the one of interest) will always be transmitted. The emitted 
light is transmitted in a narrow range centred about the specified emission wavelength and exits 
through the adjustable slits, and ultimately striking the detector. Then signal is enlarged and 
causes a voltage proportional to the measured emitted intensity [16, 18]. A luminescence 
spectrum of a sample is recorded by scanning the emission monochromator for a constant 
wavelength of the excitation light. Since the source light has different intensities at all 
wavelengths, it may vary during each experiment, causing distortion of the spectrum. This 
irregularity is corrected using an additional reference photodiode that each instrument should 
be equipped with. The reference photodiode measures a fraction of source light separated using 
a beam splitter after the exit slit of excitation monochromator before it enters the sample holder. 
By rationing the luminescence signal to the reference signal, correction is made for variation 
in excitation light intensity as function of wavelength [18].  
 
Of note, a detector should meet four basic requirements, which form critical parts of the 
spectrometer. A good detector must be able to detect a signal over several orders of magnitude 
of intensity from a few photons per second to multi-millions of photons per second. In addition 
to that, the rate of response of the detector must be faster than of the reaction in the case of 
luminescence and the signal output should be directly related to the light intensity arriving at 
it. Furthermore, it must be sensitive over wide spectral range; at the least it must cover from 
400-600 nm and ideally it should cover the whole visible spectrum. The detector that covers 
the spectral range from the ultraviolet region to the infrared region would be the best choice 
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[19]. As already mentioned in the previous section, this study used bioluminescence which did 
not require a sample to be excited by light, however, the emission was due to reaction between 
luciferin and luciferase enzyme, which produced light. 
 
4.2.3 Quantitative and qualitative analysis of samples 
Generally, luminescence based analytical techniques are used for both quantitative and 
qualitatitive analysis. In some techniques it is used for qualitative analysis only (such is 
common in disease diagnosis) and in most instances the systems or methods that can do 
quantitative analysis also do qualitative analysis. Laser induced fluorescence spectroscopy has 
been used in the diagnosis of cancer in human tissues as a qualitative mechanism. 
Luminescence cancer diagnosis is done through the introduction of a drug such as 
hematoporphyrin derivative which is selectively retained by the tumour. When excited with 
light of appropriate wavelength, the drug localized in the tumour fluoresces. This fluorescence 
is used for the detection of the tumor and also enables its imaging. Luminescence spectroscopy 
is also utilized for accurate determination of glucose which is an essential component in 
biological systems and blood glucose levels are an indicator of one’s health status. Out of range 
glucose levels provide important information of diseases such as diabetes. Glucose levels in 
the serum can be determined using a sensor based on fluorescence quenching method [20]. 
This sensor is a luminescent qualitative analytical method. Luminescence is also utilized as a 
quantitative tool in measuring ATP in mammalian cells. This is an energy carrying molecule 
found in cells of all living things, which captures chemical energy obtained from the breakdown 
of food molecules and supplies energy for other cellular processes [21].  
Since ATP is present in all metabolically active cells, it is therefore a cell viability marker. 
ATP concentrations are significantly reduced when cells undergo death via various pathways; 
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therefore, monitoring its levels provides a platform to assess cytostatic and proliferative effects 
in the environment. The amount ATP, determined by the relative luminescence units is directly 
proportional to the number of metabolically active cells in a given culture. Such assays rely on 
the properties of a thermostable recombinant luciferase, which generates a stable luminescent 
signal [22, 23]. 
 
The study of marine petroleum pollutants utilizes luminescence spectroscopy as a qualitative 
analytical technique to detect slicks of oil on the water surface, determination of petroleum 
contaminants in seawater and for monitoring petroleum derivative compounds as well as 
finding sources of water pollution. Hydrocarbons are major oil components and only a few of 
these fluoresce and petroleum strongly absorbs ultraviolet and blue light. Despite this 
luminescence is a phenomenon used in oil testing as oil luminescence covers a spectral region 
of ultraviolet and visible light (270-400 nm) [18].  
 
In the current study luminescence spesctroscopy was used for both qualitative and quantitative 
analysis to detect HIV-1 infection in TZM-bl cells and also measure luminescence intensity 
which is equivalent to virus concentration within infected cells. The results were interpreted 
as, the higher the virus concentration, the higher the luminescence intensity in cells. TZM-bl 
cells are HeLa cells engineered to express the luciferase enzyme gene when HIV-1 infection 
has taken place. Therefore, when the infected cells are lyzed with a luciferase reagent, the 
luciferase enzyme expressed in the cells reacts with the reagent and generate luminescence. 
The luminescence produced is equivalent to the number of infected cells.  
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4.3 Label-free detection of HIV-1 infection in TZM-bl cells 
This section focuses on the two techniques used in this study to assess and measure HIV-1 
infection in TZM-bl cells. Sub-section 4.3.1 covers the use and the results obtained from 
conventional method of assessing HIV-1 infection in TZM-bl, which is the luciferase assay 
using a luminometer (GloMax® Discover System). The following sub-section 4.3.2 reports on 
the detection of HIV-1 infection using the Horiba Jobin Yvon Fluorolog 3 photoluminescence 
spectrometer system, which was used for the first time in the detection of HIV infection. For 
both methods, the sample preparation was the same as TZM-bl cells were infected with 4 
different virus volumes i.e. concentrations: 50, 100, 150 and 200 μl. After 48 hours of 
incubating cells with the virus, the cells were divided into two sets so that they could be 
analyzed with the two different techniques discussed in sub-sections 4.3.1 and 4.3.2. 
 
4.3.1 GloMax® Discover System used for the detection of HIV-1 infection in TZM-bl cells 
This experiment was done in order to compare the results obtained from this established 
method with those obtained when using the Horiba detection method investigated in sub-
section 4.3.2, which is being used for the first time in the detection of HIV-1 infection. Cell 
suspensions infected with different concentrations of the pseudovirus were mixed with equal 
volume of the luciferase reagent from the Bright-Glo™ luciferase assay system (E2610, 
Promega, Anatech) in a 96 well black plate and incubated for 2 minutes at room temperature 
in the dark to allow for cell lysis.   
 
Before loading the plate for reading in the GloMax® Discover System for luminescence 
measurements, the contents of the plate were mixed by pipetting up and down. Figure 4.6 
shows the results acquired from the assay.  
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Figure 4.6 The luciferase assay used for the detection of HIV-1 infection in TZM-bl cells and quantification of 
luminescence intensities at different viral concentrations ranging from 50 μl to 200 μl. The cells infected with 200 
μl showing the highest intensity, while the uninfected cells exhibited the least luminescence levels. Significant 
differences between the infected and uninfected cells are represented on the bar columns as (*) = P < 0.05 and 
(**) = P < 0.01. Error bars represent the standard error of the mean when n =3.  
 
As expected, uninfected cells showed no luminescence, while infected cells displayed the 
presence of luminescence. The luminescence intensity in infected cells increased with the 
increase in virus concentration added in cells. According to the results obtained, cells infected 
with 50 μl had the lowest luminescence intensity, followed by the cells infected with 100 and 
150 μl, the ones infected with 200 μl had the highest luminescence intensity as shown in Figure 
4.6. 
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4.3.2 Horiba Jobin Yvon Fluorolog 3 photoluminescence spectrometer system used for 
the detection of HIV-1 infection in TZM-bl cells 
Similarly to the sample preparation used for the Glomax system in 4.3.1, cell suspensions in 
cuvettes were mixed with equal volumes of the luciferase reagent, incubated for 2 minutes in 
the dark and mixed by pipetting before loading cuvettes in the instrument for measurements. 
Figure 4.7 shows luminescence intensity plotted against a range of wavelengths (400 nm to 
800 nm) in order to assess the intensity at different viral concentrations and also determine a 
wavelength at which the luminescence in TZM-bl cells is best detected.  
 
 
Figure 4.7 Luminescence spectroscopy used to detect HIV-1 infection and measurements of luminescence 
intensities. at various concentrations (50, 100, 150 and 200 μl) of the ZM35 pseudovirus are detected around 555 
nm. 
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As represented in Figure 4.7, luminescence was observed around 555 nm, however according 
to some reports firefly bioluminescence is also observed at 620 nm [24]. Moreover, Figure 4.7 
indicates that infection in TZM-bl cells was detected and there were differences in 
luminescence intensities at different virus concentrations. With 200 μl of the virus volume 
displaying the highest intensity, followed by 150 μl, while there were no significant differences 
observed between 100 μl and 50 μl. The blank which was made of the luciferase reagent and 
the cell medium showed no luminescence (no visible peak around 555 nm), whereas the 
negative control (uninfected cells) exhibited negligible luciferase activity. Figure 4.7 also 
exhibits that 555 nm was the best wavelength for the detection of luminescence in TZM-bl 
cells in this study.  
 
The lifetime of luminescence in infected TZM-bl cells was assessed with Horiba Jobin Yvon 
Fluorolog 3 photoluminescence spectrometer system. The steady state luminescence emission 
spectra resulting from the expression of the luciferase gene in TZM-bl cells were recorded with 
a Photomultiplier tube detector. The luminescence spectra decay was recorded over a long 
period by integrating the recorded spectra time and  each spectrum was recorded at fixed time 
intervals of 1.4 minutes. The luminescence data obtained was analyzed by importing it into an 
analysis software; Microcal Origin Pro 8. This software uses the default import setting to 
import the data file to construct luminescence intensity spectra as shown in Figure 4.8. 
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Figure 4.8 Luminescence intensity spectra in TZM-bl cells. (A) Gaussian fit of HIV-1 infected luminescence 
spectrum between 450 nm and 700 nm. (B) Luminescence exponential decay fits of 546 nm, 555 nm and 580 nm 
peaks. 
 
A second order exponential decay fit was done for each of the spectrum at 546 nm, 555 nm and 
582 nm and table 4.1 summarizes the decay times at each of the three wavelengths.  
 
Table 4.1: Summary of decay times for each wavelength as displayed in Figure 4.8B. 
Peak wavelength Time in minutes (T1) Time in minutes (T2) Standard deviation 
(minutes) 
546 44.29 11.05 ±4.9 
555 53.96 53.96 ±5.20 
582 41.68 41.68 ±4.17 
 
Once the spectrum was plotted, a Gaussian function curve fitting was performed on the peaks 
of the spectrum. The red and green curves exhibited in Figure 4.8A represent the two Gaussian 
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fits; making a summation of the two Gaussian spectral peaks to one that fits the whole recorded 
spectrum. The black curve in Figure 4.8A indicates the result of the fitting. The Gaussian 
spectral function for the curves fitting was done in the region between 450 nm and 700 nm. 
Figures 4.8A and B demonstrate that luminescence was detected at lower intensities at 
wavelengths 546 and 582 nm compared to the intensity of the main peak at 555 nm. Finally, 
Figure 4.8B displays three luminescence spectra decay recorded at 546 nm, 555 nm (main 
peak) and 582 nm and the luminescence intensity at all three wavelengths decreased with time.  
 
4.4 Discussion 
Disease diagnosis involves the detection and quantification of several molecules and bio-
particles; examples include viruses, bacteria, proteins, DNA and RNA. These are analyzed 
using established methods such as biological assays (like ELISA), PCR, gel electrophoresis 
and flow cytometry [25, 26]. However, these techniques necessitate the use of labels that 
increase diagnosis costs and complexity by dependence on expensive equipment. Owing to 
this, alternative label-free methods have been developed [27]. The rise of label-free methods is 
enhanced by the growing need and interest to have medical diagnostics for tailored medicine 
and early disease detection, as well as the need for techniques that can be used in resource 
limited settings. As a result, a significant shift and/or transformation in diagnostic techniques 
has been observed. This transformation has given rise to easy to use, label-free, simple, 
sensitive, portable and cheaper means of detection [27, 28, 29]. 
 
Because of the high need of using label-free systems in disease detection, the current study 
then looked into the use of luminescence detection based on the intrinsic properties of cells. 
When focusing on inherent properties there is normally no need to use labelling.  
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A similar approach is used in the viability assay for quantification of ATP, ATP reacts with 
luciferase, luciferin and oxygen; as such, at high ATP levels, the luminescence will also 
increase [22, 23]. In this study the TZM-bl cell line was used, which is a widely used cell line 
in HIV-1 research. This cell line is engineered to express the luciferase enzyme gene when 
HIV-1 infection has taken place [30], so the presence of the luciferase gene in these cells is 
seen as an intrinsic property. Therefore, when the infected cells are lyzed with the luciferase 
reagent, the luciferase enzyme expressed in the cells reacts with the luciferase reagent and 
generates luminescence.  
 
The detection of HIV-1 infection in TZM-bl cells using the GloMax® Discover System and 
Horiba Jobin Yvon Fluorolog 3 photoluminescence spectrometer system yielded satisfactory 
outcomes. For both techniques, in the absence of HIV-1 infection there were insignificant 
luminescence levels detected as demonstrated in figures 4.6 and 4.7. The low luminescence 
levels identified in uninfected cells are as a result of endogenous bioluminescence 
(autoluminescence) which exists in most mammalian cells at low levels [31]. Furthermore, 
luminescence intensity increased with the increase in virus concentration, which signifies that 
more cells were infected with the virus as the virus concentration increased. The luminescence 
produced is presented as relative luminescence units (RLUs) and is equivalent to the number 
of infected cells. The obtained RLUs are directly proportional to the number of infectious virus 
particles present in the initial inoculum [32]. However, this occurrence is different from what 
happens in the infected individual. In an infected individual one viral particle multiplies within 
the host cells and therefore the viral load increases as the time progresses. On the other hand, 
when infecting with a pseudovirus; one viral particle that infects a cell does not multiply, 
consequently the number of viral particles that were present in the initial inoculum will not 
change after 48 hours of incubation.  
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When detecting luminescence with the Glomax Discover, no wavelength was selected as that 
system has an in-built option to measure luminescence without choosing a wavelength. 
However, when detecting luminescence with the Horiba Jobin Yvon Fluorolog 3 
photoluminescence spectrometer, it was measured over a range of wavelengths (400 nm and 
800 nm) because of the differences in luminescence wavelengths as reported in various sources 
in literature [33,34]. As such, there was a need to assess luminescence at a wider range of 
wavelengths instead of only choosing one. This was to ensure that even if it is detected at more 
than one wavelength, the wavelength where it is best emitted can be identified in this study. In 
literature, some report that 560 nm is the best wavelength to detect firefly luminescence, which 
is the luciferase present in the TZM-bl cells [24,33,35]. While others report that firefly 
luciferase can be detected between 560 nm and 570 nm. This is very close to what was observed 
in TZM-bl cells in this study. This observation is in line with various literature sources that 
mention different wavelengths and wavelength ranges at which the firefly luciferase 
luminescence is detected [24,33,34,35]. Figure 4.7 indicates that luminescence emission 
occurred around 555 nm. In addition to 555 nm, Figures 4.8A and B illustrate that luminescence 
was also detected at 548 nm and 580 nm. In both Figures 4.7 and 4.8, 555 nm is the wavelength 
with the highest luminescence intensities detected.  
 
Also, the use of Horiba Jobin Yvon Fluorolog 3 photoluminescence spectrometer offered a 
platform to assess luminescence lifetime in TZM-bl cells with ease. The luminescence decay 
was monitored for over time by setting the instrument to automatically continue with 
measurements over that period, which was unattainable when using the Glomax Discover 
system. By doing the exponential decay fit I was able to determine the luminescence lifetime 
in HIV infected TZM-bl cells.  
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Furthermore, knowing the luminescence lifetime in TZM-bl cells was necessary in order to 
have an idea of how long it would take for a signal to diminish when a similar system is used 
in label free diagnostic devices.  
 
For the purposes of developing luminescence based smart diagnostic devices for HIV-1 
diagnosis, TZM-bl cells are the most ideal choice of cells because they already have the 
luciferase gene. Therefore, detection and quantification of HIV-1 infection in TZM-bl cells 
shows that when doing thorough studies on cellular molecules affected during HIV-1 infetion 
(or any other infection/diseases) it is possible to come up with luminescence based label-free 
disease detection systems, which would add value and reduce costs associated with disease 
diagnosis. For the first time, in this study I showed that HIV-1 infection in TZM-bl cells can 
be detected using the Horiba Jobin Yvon Fluorolog 3 photoluminescence spectrometer. Such 
findings are encouraging and have also highlighted that there is possibility of using 
luminescence not only for HIV detection, but also for detection and analysis of other biological 
metabolites. As such our future research studies will focus in the development of luminescence 
based analytical systems for various metabolites. 
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Chapter 5 
 
Single molecule analysis in HIV-1 infected cells using structured 
illumination microscopy (SIM) 
 
Introduction 
The main focus of chapter 5 is the detection of HIV infection in TZM-bl cells using structured 
illumination microscopy (SIM). Section 5.1 gives an overview on super resolution microscopy 
(SRM) by briefly summarizing microscopy history in 5.1.1 which led to the development of 
SRM. The development of SRM is followed by describing how the different SRM techniques 
pass diffraction limit for the observation of nanometer molecules. Sub-section 5.1.3 reports on 
how SRM has been previously applied through giving a brief literature review.  Then, sections 
5.2, deals with the mechanisms of SIM, which give this technique the capability to go beyond 
diffraction limit. Further in 5.2, the generation of Moire patterns, which is an essential 
characteristic of the SIM is described. Following that, in section 5.3, reports on various studies 
that have been conducted using SIM. Of note, section 5.3 is followed by section 5.4 which 
discusses HIV molecules detected in this study. The following section; section 5.5 reports on 
what the current study focused on, which is the use of SIM for the detection of HIV infection 
in TZM-bl cells. The results obtained in section 5.5 are discussed in section 5.6.  
 
 
 
125 
 
5.1 Overview of super resolution microscopy 
5.1.1 Development of super resolution microscopy 
Microscopy uses visible light and well-arranged lenses to both detect and magnify small 
(microscopic) objects that are difficult to resolve with a naked eye [1]. Light microscopy has 
been extensively used in medical and biological fields for its ability to visualize and investigate 
organs, tissues, cells and microorganisms. Therefore, light microscopy led to many discoveries 
(or acquiring of new knowledge) with magnification playing a significant role as it enlarges 
invisible substances and makes them look bigger and visible [2]. However, simple light 
microscopy even with high magnification is not adequate to visualize cellular molecules and 
processes because of a limit in optical resolution caused by the diffraction of visible light when 
it passes through a round aperture at the back focal plane of an objective [3]. Our environment 
has various organisms and structures of different sizes; ranging from metres (m) to nanometres 
(nm) (Figure 5.1) and there is no single imaging technique to visualize all organisms.  
 
 
Figure 5.1 Various sizes of organisms and molecules that are visualized with different techniques. The blue 
shaded region shows organisms in the millimetre (mm) and micrometre (µm) size range that can be visualized 
with either a naked eye or standard optical microscopy. The red shaded region shows organisms and molecules in 
the nm size range that cannot be visualized using standard light microscopy, but require super resolution 
microscopy [4]. 
126 
 
Organisms in the millimetre range and above are visible in the human eye, those in micrometre 
range can only be visualized using standard optical microscopes and those in the nanometre 
range (below 200 nm) can be visualized with super resolution imaging systems. The limit in 
optical resolution led to the generation of fluorescence microscopy. In fluorescence 
microscopy, cellular and subcellular configurations and components could be observed through 
molecule specific labelling independent of nearby molecules and due to high contrast of 
fluorophores to a dark background [5]. Despite these improvements, conventional fluorescence 
microscopy is restricted in its ability to differentiate between tiny and closely-spaced items as 
separate objects. Diffraction limit hinders the resolution of structures below 200 nm as it was 
first described by Abbe 1873 [6,7]. Owing to the wave nature of light, a point source of light 
in the sample plane of the microscope cannot be re-focused to a single point in an image, but 
the light is diffracted to form an intensity distribution known as the point spread function (PSF), 
with a size defined as 𝑑 ≈
𝜆
2𝑁𝐴
 in the lateral plane and defined as 𝑑 ≈
2𝜆𝑛
𝑁𝐴2
 in the optical axis.  
 
Thus, the resolution of conventional fluorescence microscopy is limited to a diameter of about 
200 nm in the lateral plane; and >450-700 nm in the optical axis; wherein λ is the wavelength 
of light and NA is the numerical aperture of the objective and n the refractive index [8]. The 
PSF is the stable size of the spread of a single point of light that is diffracted through a 
microscope and an object that can be resolved by a microscope. Objects of smaller size seem 
to be the same size as the PSF and those closer than the width of the PSF are not seen as separate 
objects. Thus, if two small objects are positioned within the width of a PSF, they become 
indistinguishable [5,9,10]. Even so, the recent years have seen a rise in unprecedented technical 
innovations of super resolution microscopy which have altered the limits of optical resolution 
from around 250 nm to about 10 nm [11].  
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Thus, super resolution microscopy was developed to overcome the resolution limit of 
conventional fluorescence microscopy. The next sub-section 5.1.2 describes how resolution is 
enhanced beyond the diffraction limit thereby enabling the observation of nanometre 
structures. 
 
5.1.2 Observation of nanometre structures by passing the diffraction limit of light 
In response to the shortcomings of conventional fluorescence microscopy, several imaging 
systems such as confocal microscopy and multiphoton fluorescence microscopy have gone 
beyond the diffraction limit of light microscopy [12]. In confocal microscopy, the resolution 
of the image is generally determined by the size of the focused light spot typified by the PSF. 
When the excitation PSF is smaller, the image would be more precise. Two closely located 
objects can be well resolved when using confocal microscopy if they are parted by at least 180-
300 nm [13]. Confocal microscopy provides some advantages over conventional fluorescence 
microscopy as it reduces background information from the focal plane and also controls depth 
of field (Figure 5.2). It uses spatial filtering techniques to remove out of focus glare in samples 
with thickness greater than the closest plane of focus [14].  
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Figure 5.2 Images that compare standard fluorescence microscopy and confocal fluorescence microscopy. In (A), 
a fluorescently stained human medulla with standard microscope exhibiting intense glare, (C) imaged with laser 
scanning confocal microscope fluorescent revealing a significant structural detail of the medulla. (B) A standard 
fluorescence microscopy blurred image of whole rabbit muscle fibres stained with fluorescein and (D) a more 
resolved whole rabbit muscle fibre imaged with confocal microscopy [14]. 
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Despite this significant improvement, these systems are still limited by diffraction [15]. In order 
to achieve spatial resolution and overcome the diffraction limit, a number of super resolution 
fluorescence microscopy methods such as stimulated emission depletion (STED) microscopy, 
reversible saturable optically linear fluorescence transitions (RESOLFTs), structured-
illumination microscopy (SIM), stochastic optical reconstruction microscopy (STORM), 
photoactivated localization microscopy (PALM), fluorescence photoactivation localization 
microscopy (FPALM) and saturated excitation (SAX) have been developed. In these new 
systems developed to beat the diffraction barrier, the key aspect is to make use of fluorescent 
molecules. This can be achieved by using various means such as stimulated emission, 
structured illumination, photoactivation, cis-trans isomerization, triplet pumping, saturated 
excitation. To this point, almost all super resolution microscopy applications are dependent on 
the excitation and emission properties of fluorescent tags to solve the diffraction limit [2]. 
These systems offer a spatial resolution of 10 to 100 nm and the most recent developments 
have reported that 1 nm resolution is achievable [16].  
 
In general, all these methods generate diffraction unlimited images by using the physical 
characteristics of fluorescent tags to distinguish emissions from two adjacent molecules within 
a diffraction limited section. The systems fall into two classes; the first class uses patterned 
illumination to spatially modulate the fluorescence behaviour of molecules within a diffraction 
limited area, such that they do not illuminate at the same time, thereby achieving sub-
diffraction limit resolution. Systems in this class are STED, RESOLT and SSIM 
[17,18,19,20,21]. The second category uses single molecule imaging, which uses photo-
switching or other means to randomly activate separate molecules within the diffraction limited 
region at different times. Images with sub-diffraction limit resolution are then reconstructed 
from the measured positions of individual fluorophores.  
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This class includes systems such as STORM, PALM and FPALM [22,23,24]. Now that I have 
described how super resolution microscopy beats diffraction limit, the next sub-section 5.1.3 
discusses the applications of SRM in biological systems to demonstrate its efficiency. 
 
5.1.3 Super resolution microscopy applications in biological systems 
Super resolution microscopy (SRM) has been widely applied in many biology fields and it is 
expanding to other fields. In this section, I will summarise a few examples including some uses 
of SRM thus far. Super resolution microscopy has aided the studying of numerous subcellular 
components and much knowledge has been generated. Because of it, abnormalities or diseases 
in living organisms can be detected at molecular level. At the early stages of SRM techniques, 
various subcellular structures (such as microtubules, focal adhesion complexes, endoplasmic 
reticulum, actin and mitochondria) with well-characterized features were often used as proof 
of concept model systems [25,26,27]. Such studies demonstrated both the systems’ capabilities 
to visualize molecular structures and synergies in the cellular environment [6]. 
  
Super resolution microscopy has provided a platform to understand plasma membrane. In 
general, plasma membranes are mostly made up of lipids and proteins; and their compositions 
vary among organisms and organelles [28]. The composition of molecules on the cell 
membranes has not been fully studied because of diffraction limit as these molecules are nano-
scale structures that could not be visualized with conventional imaging systems [29]. The 
molecules on the cell membrane have various functions, including those involved in the 
immune systems and disease development in various organisms, such as the use of CD4 
receptor and CCR5 co-receptor for HIV infection [30].  
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The configuration of immune receptors has been comprehensively studied by super resolution 
systems. Using STED, the interaction between parasites and the plasma membrane; for 
example, maturation-induced clustering of HIV Env proteins that depends on the Gag 
interacting env tail has been shown [31]. In a similar fashion, PALM and STORM has been 
used to understand the interaction between the host and the virus [32,33]. 
 
In another study they showed that the Bax protein organises as ring like structures in apoptotic 
cells [34]. Bax protein is situated on the mitochondrial membrane of apoptotic cells and plays 
a major role in apoptosis. Its build-up and oligomerisation leads to the release of cytochrome c 
and ultimately cell death. This observation shed more light on how the abundance of Bax 
protein contributes to cell death via apoptosis [34,35]. The mitochondrial inner membrane 
system is suggested to be essential in the protein network that regulates mitochondrial function 
and structure. The clusters of this system and their distribution in the mitochondria have been 
illustrated by STED [36]. In the same manner, cytochrome c oxidase subunit 2 in the 
mitochondria was spotted by STED [37]. 
 
Through SRM, we are gaining more understanding of the molecules contained within the 
nucleus [6]. The analysis of highly compact DNA packaging and its interaction with proteins 
within the nucleus can only be achieved using super resolution imaging [6]. For instance, 
studies with 3D SIM showed morphological fluctuations of chromosomes and nuclear lamin 
during early mitosis [38]. In another study, STORM exhibited a great potential in resolving 
chromatin fibers [39]. Backer and team created a method of examining the structure of 
individual DNA strands, and also characterizing DNA-dye interactions [40].  
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The ability to obtain such crucial information is essential in detecting diseases due to 
abnormalities at molecular level.  
 
Super resolution microscopy has massively contributed to the understanding of HIV-1 
replication, which would have been difficult to achieve with conventional microscopy as HIV 
is between 120 and 140 nm in diameter [41]. Furthermore, the understanding of HIV-1 
replication has contributed in the discovery of anti-HIV treatment. Therefore, SRM is among 
the technologies/techniques that have significantly contributed towards achieving the great 
successes obtained thus far in the field of HIV-1 research. Using STORM, it was demonstrated 
that Gag assembly at the surface of infected cells regulates both env mobility and distribution 
in an env cytoplasmic tail manner [32]. Such a process secures env incorporation into newly 
produced viral particles and also prevents the premature activation of env fusogenecity, thereby 
avoiding syncytia formation [32]. This understanding is essential as it is has a potential to lead 
to the development of an anti-HIV drug that would interfere with this process, thereby 
producing non-infectious viral particles.  
 
In another study they successfully imaged the HIV integrase enzyme (IN) at approximately 30 
nm using FlAsH-PALM [42]. The obtained resolution permitted them to characterize the 
spreading of integrase within the virions and to distinguish diverse HIV structural populations 
according to their morphology [42]. Using direct STORM, the changes in the molecular 
distribution of viral proteins during the infection have been visualized [43]. Mentioned here 
are only few examples illustrating the significance of various SRM techniques used in 
biological sciences. The next section will focus on the mechanisms of structured illumination 
microscopy (SIM), which is the technique used in this thesis. 
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5.2 Mechanisms of structured illumination microscopy 
SIM is a structured illumination technique which uses structured illumination and 
computational reconstruction to attain up to two times better resolution than the diffraction 
limit. The grating structured excitation light is shed on the fluorescence distribution of the 
sample to generate Moiré fringes (Figure 5.3) that have spatial beat frequency from between 
the structured excitation light and the fluorescing sample [44]. Under normal illumination with 
no striped pattern (homogeneous illumination), the point spread function of the objective makes 
it difficult to distinguish between objects separated by a distance bigger than 200 nm. This is 
because the high spatial frequency information of the sample missing in conventional 
microscopy can be identified by imaging the Moiré patterns, which have a lower spatial 
frequency than the sample. Yet with structured illumination, the overlap between the high 
frequency arrangement of entities within the sample and the high frequency of the illumination 
lines form a design of lower frequency permitting to make a distinction between two objects 
parted by 200 nm [44]. 
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Figure 5.3 Diagram explaining Moiré effect and the SR-SIM principle. A sample with an unknown pattern is 
illuminated with a known grating pattern on the microscope objective. When the two un-identical patterns are 
superposed generate moiré fringes with an unresolved image. The unresolved image formed is reconstructed to 
give rise to the final resolvable image [44,45]. 
 
Finally, to produce a highly resolved image, sub-diffractive information is extracted and 
numerous unprocessed images must be put together, each being attained at different angles of 
the structured illumination. This is achieved by shifting the diffraction grating (rotation and 
translation); therefore high resolution is acquired by scanning the sample from different angles 
in the presence of the Moiré pattern. SIM images can be acquired either in a three dimensional 
(3D) format or two dimensional format depending on the number of times the diffraction 
grating shifting takes place.  
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To obtain a 3D image, 15 images are to be acquired using 3 rotations and 5 translations, 
whereas the 2D image is obtained with 9 unprocessed images with 3 rotations and 3 translations 
[46].  
 
Structured illumination microscopy has a spatial resolution that increases by two over the 
conventional wide-field microscopy and it uses standard dye which makes it less expensive 
[44]. Furthermore, SIM can use up to four wavelengths; making it a useful method to access 
multiple resolved information inside cells and suitable for live cell imaging, with high imaging 
speed while its sample preparation is not complicated [47,48]. Despite its attractive features, it 
also has a few limitations, such as sensitivity to out of focus light and difficult to focus in thick 
and densely labelled samples as well the possible generation of artefacts during the image 
reconstruction, which can ruin the quality of images [49,50]. 
 
5.3 Applications of structured illumination microscopy  
Commercial forms of SIM are widely used for imaging either extensions or replacements of 
conventional fluorescence microscopes such as scanning confocal microscopes. Thus far, the 
use of these systems is mostly observed in structural biology studies using fixed cells. 
However, live cell imaging is gradually emerging in time lapsed studies. Besides applications 
in cell biology, SIM has been used in studying bacterial processes and analysis of viral 
structures. The slow movement of SIM in live cell imaging is due to the speed with which the 
illumination pattern is produced and moved through the specimen, as well as not yet fully 
optimized image acquisition time in some systems. Despite the slow progress in SIM live cell 
imaging, a lot has been done in as far as structural biology studies.  
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In one study 3D-SIM was used for structural analysis of the dissemination of chromatin in 
mammalian cells nuclei [51]. Here, up to three different colour channels were concurrently 
used to visualize chromatin in fixed C2C12 myoblast cells. This was done along with the 
nuclear pore complex and nuclear lamina. In that study they were able to resolve single nuclear 
pore complexes which co-localized with channels in nuclear lamina [51]. The three 
dimensional imaging depth of SIM and specificity of fluorescently stained antibodies has made 
it possible to co-localize structural proteins in all dimensions. Due to this ability, the 
visualisation of replication foci down to single replicons has been demonstrated [52]. In another 
study, Regev-Rudzki supplemented biochemical analysis techniques with SIM to reveal that 
Plasmodium falciparum infected red blood cells use exosome like vesicle for communication 
between parasites [53]. In a similar study they investigated how the parasite exports proteins 
and remodels red blood cell structures to ensure that parasites inside infected cells survive [54]. 
 
Besides cell biology applications, SIM has also been employed in microbiology in which it has 
opened a platform for many new possibilities. Several studies in microbiology have studied the 
distribution and the structure of FtsZ, which is a bacterial homologue of eukaryotic cell tubulin, 
which assembles into so called Z ring leading up to bacterial cell division. In Staphylococcus 
aureus, Escherichia coli and Bacillus subtilis SIM demonstrated that Z rings are patchy and 
discontinuous rather than forming a continuous structure [55,56]. Time lapse imaging enabled 
them to show that the localization of FtsZ with the Z ring is dynamic and remains 
heterogeneous throughout the cell division process. These illustrate how efficient this 
technique is to get to such nano-scale detail. In another study they used SIM to follow the 
development of the repair of DNA double stranded breaks in living bacterial cells [55].  
They were also able to determine the sequence and stoichiometry at which non-identical 
bacterial enzymes have to assemble at the site of DNA double stranded breaks in order to 
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identify and repair the local damage. They found that enzyme RecA, which is a repair enzyme, 
forms packages to regulate the search for damage sites [56]. The use of SIM has shed some 
light on the position of enzymes involved in bacterial cell division. They used pulse labelling 
of diving bacteria with fluorescent amino acids and observed that the peptidoglycan septum is 
continuously made from the cell surface inward and the synthesis takes place at separate 
locations that circle around the division level. These studies are clear demonstrations that 
enhancing resolution has brought about new biological insights [57].  
 
In the utilisation of SIM for the analysis of viral structures, individual vaccinia virus particles 
were imaged to track virus morphogenesis and maturation by using a fluorescent viral clone 
[58]. Due to the 3D nature of the system, they were able to determine the viral envelope protein 
B5 as a spherical shape enclosing the virus core, which offers a way of evaluating the degree 
of maturation of virus particles [58]. A different group used SIM to understand the structure of 
viral replication complexes of potato virus X [59]. In this chapter SIM is used to check for 
HIV-1 molecules in infected cells, with the goal to eventually couple the system with optical 
trapping for diagnostic purposes. 
 
5.4 HIV-1 molecules detected in this study  
In chapters 3 and 4 HIV-1 infection was detected by optical trapping coupled with transmission 
spectroscopy and luminescence spectroscopy, respectively. In chapter 5, I am reporting on how 
SIM was used for the detection of HIV-1 infection in TZM-bl cells by single molecule analysis, 
i.e. identifying two HIV-1 molecules; gp41 and p24 in infected cells. For both optical trapping 
and luminescence spectroscopy, no viral molecules were detected, but HIV infection detection 
was due to the changes caused by the virus in the cells. In this chapter HIV infection detection 
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in TZM-bl cells is based on detecting viral molecules in the infected cells. This was done to 
ascertain that individual molecules of the virus can be detected in infected TZM-bl cells using 
green fluorescently labelled HIV antibodies and SIM.  
 
HIV and its molecules are less than 200 nm in size and therefore they cannot be clearly imaged 
or visualized with conventional microscopy, hence this study used SIM. The matured human 
immunodeficiency virus is around 145 nm in diameter [60]. The virus is roughly 9.8 kilobases 
in length with nine genes coding for 9 different proteins, which are Env, Pol, Gag, Rev, Tat, 
Nef, Vpu, Vif and Vpr. The proteins are in three classes, structural, regulatory and accessory 
proteins [61,62]. However, for the purposes of this work, the focus was on molecules generated 
from two structural proteins; Env and Gag, which are gp41 and p24.  
 
The diameter of gp41 according to the electron microscopy analysis was found to be 
approximately 12.4 nm [63]. The p24 diameter of a matured HIV particle is 55 to 62 nm in 
diameter on the wide end, and 25 nm in diameter on the narrow end, while the capsid shell is 
120 to 130 nm [64]. The differences on the two opposite ends of the capsid (p24) can be seen 
in Figures 5.4 and 5.5. The capsid protein, p24 (CA) is a 24 kilo-Dalton (kD) protein coded for 
by the viral Gag structural protein that makes the conical core (as depicted by the navy blue 
structure in figure 5.4) of viral particles [65]. 
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Figure 5.4 Human immunodeficiency virus depicting different virus components. The pink and green trimeric 
structures on the surface of the virus are gp120 and gp42 envelope proteins, which essential for the entry of the 
virus into the host cell. They are embedded onto the lipid membrane of the virus. The capsid encloses viral 
enzymes such as reverse transcriptase and the RNA viral genome and it is the most abundant component of the 
virus made of thousands copies of the p24 protein [66].  
 
Each viral particle contains approximately 2000 to 4000 p24 molecules (as illustrated in Figure 
5.5), making it the most abundant HIV molecule [67].  
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Figure 5.5 The HIV capsid with roughly 2000 copies of the p24 protein. The cone shape of the capsid provides 
the virus with its conical shape. It is the viral protein that encloses the viral RNA and core proteins of the virus 
[68]. 
 
The p24 antigen emerges within 2 weeks of HIV infection due to the early rapid viral 
replication resulting to high levels of the virus; with the infected individual being highly 
infectious [69]. At both early and late HIV infection stages p24 is always at high levels, 
rendering it a marker of choice for diagnosis [70]. For early diagnosis of HIV infection, p24 
protein (antigen) is detected and its early detection has reduced the window period to about 17 
days post-infection and enables acute infection identification [71]. The detection of p24 antigen 
is disrupted by the rise of antibodies, which is most likely due to the development of antigen-
antibody complexes in the blood [69]. Since p24 is the most abundant viral molecule, it is the 
antigen of choice to detect for infant HIV diagnosis as the use of antibody tests could lead to 
false positive results due to the presence of the mother’s antibodies present in the child [69]. 
 
The glycoprotein 41 (gp41) is a 41 kD protein which is part of the gp160, a160 kD envelope 
(Env) structural protein of HIV. Gp 41, an envelope transmembrane protein (the green trimeric 
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structures in Figure 5.4) coded with gp120, an envelope surface protein (illustrated by the 
purple trimeric structure in Figure 5.4) [72]. The gp160 envelope protein is the HIV surface 
protein responsible viral entry into the host cell. While gp120 is mainly responsible for viral 
attachment as it binds to the CD4 receptor and co-receptor (CCR5 or CXCR4). During 
attachment conformational changes in both gp120 and gp41 occur, thereby exposing a gp41 
region which facilitates fusion of the virus to the host cell membrane [73]. Therefore, gp41 
plays a crucial role in HIV infection so much that there is an antiretroviral drug, Enfuvirtide 
which is a fusion inhibitor [74]. 
 
5.5 Detection of HIV infection in TZM-bl cells using structured illumination microscopy 
The TZM-bl cells were infected with ZM53 HIV-1 pseudovirus and incubated for 48 hours 
before being labelled and imaged with Carl Zeiss Confocal LSM 780 Elyra S1 with SR-SIM. 
The images obtained were analyzed and processed using the Zeiss ZEN lite software in order 
to obtain clear images of the samples. The results obtained revealed that both gp41 and p24 
were well detected in infected TZM-bl cells using confocal microscopy and SIM as illustrated 
in Figure 5.5.  
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Figure 5.6 Images of labelled TZM-bl cells captured using confocal microscopy and separately SIM showing 
gp41 and p24 in HIV-1 infected TZM-bl cells. Figure A is an uninfected sample of TZM-bl cells with no green 
staining, while figure B exhibits HIV-1 infection through green fluorescent gp41 sections on the cells following 
imaging via confocal microscopy. In figure C a control sample of uninfected cells is compared to infected cells in 
figure D, where the p24 protein is expressed as green fluorescence after confocal microscopy scanning. The 
micrograghs in E and F are the 3D snapshots displaying gp41 and p24 respectively in infected cells captured via 
SIM. 
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The blue background in images displayed in Figure 5.6 is as a result of staining cells with the 
Hoescht dye, which stains the cell nucleus and therefore both infected and uninfected cells 
appeared blue. In addition, the infected cells (Figures 5.6B, D, E and F) also had a green 
fluorescence because the secondary antibody was attached to a green fluorescent marker, Alexa 
488. So the infected cells have green fluorescence which indicates that the viral antibodies used 
indeed were bound to the viral molecules on the infected cells. Therefore, the presence of the 
green fluorescence was a confirmation that indeed the cells were infected with HIV. On the 
other hand, the uninfected cells have no green fluorescence which signifies that no viral 
molecules were detected in them.  
 
5.6 Discussion  
The main aim of the experiments done in this chapter was to confirm what had been revealed 
by other techniques such as luminescence detection, optical trapping coupled with transmission 
spectroscopy; that indeed the cells were infected with HIV by visually demonstrating the 
presence of HIV molecules in the infected cells (Figure 5.6B, D, E and F). The results obtained 
showed that SIM and confocal microscopy successfully detected HIV infection in TZM-bl cells 
infected with the ZM53 HIV-1 pseudovirus. This finding confirmed that indeed SIM has better 
resolution compared to conventional light microscopy, as viral molecules between 12.4 nm and 
130 nm were viewed [44, 63, 64]. This correlates well with what has been shown previously, 
where Hulme et al 2015 showed that viral complexes found in the nucleus exhibited a lesser 
amount of p24 compared to complexes localized at the nuclear membrane and in the cytoplasm 
[75]. In that study they were able to observe different intensities of p24 at different sites and 
stages [75]. In another study, the number and localisation of p24 foci post infection was 
successfully identified and the p24 foci sizes which vary throughout the virus interaction with 
the cell using SIM were determined [76].  
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By using confocal microscopy to examine gp41 membrane topology, Liu et al 2010 confirmed 
that gp41 has a single membrane spanning domain [77]. This was necessary after a different 
topology model had suggested that gp41 has multiple membrane spanning domains [77].  
 
Furthermore, Figures 5.6A and C which are images of uninfected cells display the specificity 
of the HIV antibodies used because no fluorescence was detected in uninfected cells despite 
labelling them in the same way as the infected ones. This demonstrates that the SIM images 
acquired did not have background noise that would make interpreting results confusing. It 
further validates the efficiency of the ZEN lite software used for analysis, as it meticulously 
extracted all the valuable information thus enabling the differentiation of the two cell 
populations with great ease. The analysis with ZEN lite was necessary as the formation of 
moire fringes (as described in section 5.2 and illustrated in Figure 5.3) obscure the valuable 
information in the acquired images which necessitates that the acquired images must be 
processed in order to attain well resolved images that would display what was in the 
experimental cells. The images in Figure 6 clearly prove that the ZEN life software effectively 
processed the images. This is worth noting as one of the limitations of using SIM is that 
artefacts may be generated during image reconstruction which tends to ruin the quality of 
images [50]. Therefore, these findings show that there were no artefacts generated. 
 
Additionally, the simplicity of sample preparation and the use of conventional dyes when 
imaging cell molecules made SIM an attractive imaging option for this study, without 
compromising the results obtained and using expensive techniques [44]. Being able to 
successfully use SIM and confocal microscopy for the detection of HIV infection in TZM-bl 
cells emphasizes the notion that the type of SRM is chosen based on the purpose of the 
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experiment and the desired goal. In addition, even with confocal microscopy we were able to 
detect p24 and gp41, however using SIM had an added advantage as the images could be 
viewed in a 3 dimensional manner as shown in Figures 5.6 E and F. Whereas confocal 
microscopy images in Figures 5.6 B and D the images could only be viewed from a single 
dimension. 
 
Successfully imaging and visualising virus molecules in the infected cells, gives the confidence 
that coupling of the SRM imaging systems with a trapping system would enable the studying 
of individual cells in order to see the inherent cellular properties thus differentiating between 
HIV infected and uninfected cells. Such a step would enrich the study as we will be able to 
study intrinsic properties of cells which would lead to the development of label free detection 
systems that would fulfil the ultimate goal of developing affordable point of care diagnostic 
devices for resource limited settings.  
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Chapter 6 
 
Conclusion 
 
This chapter presents a conclusion on the five chapters of this thesis and future work regarding 
the findings in each of the chapters. In chapter 1, a concise report about HIV, its pathogenesis, 
various types and subtypes, and other topics associated with it such as treatment challenges and 
its global distribution are outlined. Furthermore, techniques used in this work such as LLLT 
for HIV infection control, optical trapping, spectroscopic analysis and single molecule analysis 
for the detection of HIV-1 infection in TZM-bl cells are summarized before their applications 
are explored in subsequent chapters. The laser driven systems were used for both the treatment 
and diagnosis of HIV-1 infection in TZM-bl cells, as lasers have properties that are beneficial 
in the biological and medical sciences. The outcomes of the study showed that the use of laser 
based systems for treatment and diagnosis is effective and has a great potential in the field of 
medicine. 
 
In Chapter 2, a brief history of lasers is given followed by the principles of laser while 
highlighting the role of each component as well as the two modes of laser output. An overview 
of laser therapy is outlined by describing the history of light therapy, the mechanisms of LLLT 
while drawing attention to various cellular components that are necessary in order for a therapy 
to yield beneficial results. This is then followed by an extensive discussion on the choice of 
laser wavelength as various wavelengths interact differently with biological material (tissues, 
cells and organelles) and thereby yielding different results. The interaction of laser with 
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biological matter according to wavelengths was explained in order to give guidance on the laser 
choices for various experiments in the field of Biophotonics. 
 
Chapter 2 focused on the use of LLLT towards controlling HIV-1 infection in TZM-bl cells. 
The results obtained showed a significant reduction in HIV-1 infection in laser irradiated cells. 
Moreover, as the fluence increased there was further reduction in infection and an increase in 
undesirable effects on cells was observed. Furthermore, the fluence could not be increased 
beyond 10 J/cm2 as that would have increased the exposure time to more than an hour as the 
power of the laser used was only 30 mW on the sample stage. The fluence is dependent on 
laser power output, time and the area to be irradiated. When the power is low, the irradiation 
time would be longer. Nonetheless, the response of cells to irradiation is also dependent on the 
cell type; it is possible that other cells types would have less undesirable effects compared to 
the ones observed in TZM-bl cells used in this study. Moreover, the wavelength used also 
influences how the cells respond to irradiation, with more studies it is possible to find the best 
wavelength that would successfully reduce HIV-1 infection in TZM-bl cells and also have less 
undesirable side effects. Of note, in LLLT, there are no standard factors to achieve a desired 
goal; the efficacy of LLLT based studies are largely influenced by the cell/tissue type and the 
laser wavelength used, and therefore there are variation between studies.  
 
Additionally, the combination of LLLT and efavirenz further reduced HIV-1 infection in TZM-
bl cells and the cells irradiated at 10 J/cm2 in the presence of efavirenz showed a reduction in 
infection that was comparable to the uninfected cells. That outcome was a good indication that 
combining these two unrelated therapies has a great potential.  
Such an outcome is promising in the search for an effective HIV treatment as there is a 
possibility that eventually there could be a way of eradicating HIV infection. Currently, HIV 
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infected individuals have to be on a lifelong treatment, so far, the available treatment has been 
unable to get rid of the virus that is lying dormant in the various latent sites within the human 
body. It is the presence of those latent sites that requires the continuous use of the treatment as 
the discontinuation of the treatment would lead to the emergence of drug resistant strains of 
the virus, thereby complicating the disease as there could be unavailability of effective 
treatment [1]. However, if LLLT would be effective there would be an alternative treatment 
and also a new form of treatment that has a potential to lead to complete eradication of the 
infection. Moreover, based on the reports of the use of LLLT in the treatment of other medical 
conditions, LLLT is reported to have fewer side effects compared to the use of drugs [2]. In 
the case of HIV treatment, over the years the treatment has improved and the current treatment 
has lesser side effects compared to the treatment that was used initially [3]. Despite that 
improvement, which has made the treatment to be tolerable and therefore increased adherence, 
the treatment is still life long. That is a challenge and therefore an alternative treatment 
modality which has a potential to eradicate the infection is desirable. Therefore, the next phase 
of the study would be looking into the use of other laser wavelengths on different cell types 
and eventually select the most effective wavelength for the irradiation of HIV infected cells. 
Also, further investigations will be done in order to establish the laser treatment mechanisms 
that lead to the reduction of HIV infection in TZM-bl cells. The ultimate goal of this study is 
to develop a device that would be used for HIV treatment at point of care. The work reported 
here was done in vitro with one wavelength and one type of cell line. 
 
 
Chapter 3 of this thesis was based on the use of optical trapping and transmission spectroscopy 
for label-free detection of HIV-1 infection in TZM-bl cells. The chapter begins by giving an 
overview on the various optical trapping modes, followed by a description of forces that govern 
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optical traps; the influence of wavelengths, particle sizes and the role of the Q value method to 
determine trapping efficiency in optical trapping systems. Thereafter the assembling of an 
optical trapping system (Figure 3.7) used in this thesis was provided, followed by a 
demonstration of trapping 2 μm polystyrene beads (Figure 3.8) and 25 μm TZM-bl cells (figure 
3.9) using the newly assembled setup. The ability to trap both the beads and cells showed that 
the trapping system was working well and of good efficiency. The capably functioning trapping 
system was then coupled to a transmission spectroscopy in order to analyze individually 
trapped cells for the detection of HIV-1 infection.  
 
The results obtained revealed that the infected and uninfected cells had different transmittance 
percentages, with uninfected cells transmitting more light as compared to the infected cells 
(Figures 3.13 and 3.14). These findings were a clear indication that these two cell populations 
interacted differently with light and those differences enabled differentiation between HIV 
infected and uninfected cells without using any labels, stains or bio-markers. The following 
phase of this study would be to determine scientific reason behind the two cell populations 
behaving differently in transmitting light. Therefore, factors such as oxygen content, nutrient 
levels, and cell diameter variations would need to be assessed. So far, it can be said that the 
presence of the virus in the infected cells caused lesser light to be transmitted in the infected 
cells due to differences in refractive indices of the infected and uninfected cells. Furthermore, 
additional measurements and analyzes will be performed through coupling the optical trapping 
system with Raman spectroscopy, which is more sensitive than transmission spectroscopy 
applied in the current phase of the study.  
The ultimate goal of the work of chapter 3 is to develop a laser driven system that would be 
used at a point-of-care for HIV diagnosis. 
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Chapter 4 is about the detection of HIV-1 infection in TZM-bl cells using luminescence 
spectroscopy. The chapter opens by discussing luminescence mechanism, which involves the 
processes that lead to the development of luminescence and then specifically touches on 
bioluminescence; the type of luminescence that was used in this study. The chapter goes on 
into discussing principles of luminescence spectroscopy as well as the elements that are 
essential for a luminescence spectroscopy system (Figure 4.5), followed by the summary of 
where luminescence has been used for analytical purposes. As the chapter continues, it shows  
that for the first time HIV-1 infection in TZM-bl cells was detected using the Horiba Jobin 
Yvon Fluorolog spectrometer (Figure 4.7) and the findings are comparable with the use of a 
luminometer (a widely used system). The use of the Horiba Yvon Fluorolog spectrometer was 
of great benefit as the luminescence decay was monitored with more ease in comparison with 
the luminometer.  
 
With the Horiba Yvon Fluorolog the luminescence decay curve was monitored automatically 
and that cannot be achieved on a luminometer. Besides just being able to detect HIV-1 infection 
in TZM-bl cells, the ease of working with this system would be of benefit in the assay such as 
ATP measurement and even in the establishment of other new assays that need luminescence 
detection. The detection and quantification of the infection in TZM-bl cells using luminescence 
spectroscopy highlighted the importance of inherent cellular characteristics in disease 
diagnosis, because the presence of the luciferase gene in TZM-bl cells is what enables the 
detection of HIV infection as the luciferase gene is only expressed when HIV infection has 
taken place.  
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Despite the yet unknown system in human blood cells that could act in a similar manner, the 
findings of this experiment are an encouragement to continue searching for a molecule or a 
system in the human blood cells or human cells in general that can only be detected with laser 
when HIV infection has occurred. The current tests use antibodies and since we are moving 
towards simplifying diagnostics tests, further improvements are necessary.  
 
In chapter 5, Structured Illumination Microscopy was used for single molecule analysis in HIV-
1 infected TZM-bl cells. Firstly, in section 5.1 the overview of super resolution microscopy is 
discussed by summarizing its development, examining its ability to pass the diffraction limit 
of light in order to observe nanometer structures and how the passing of the diffraction limit 
has enabled for many successful investigations to be done in nano and micro scale biological 
systems. The chapter then focuses on the principles of SIM as it uses Moire fringes in order to 
provide structured illumination so that a clear distinction between objects separated by 200 nm 
may be made. Later on in sections 5.4 and 5.5 SIM is used for the detection of HIV-1 molecules 
in TZM-bl cells. HIV infection in TZM-bl cells was successfully detected or confirmed by 
picking viral molecules using SIM and confocal microscopy. The detection of HIV molecules 
in infected cells is an established system, which was used in this study to ensure that viral 
molecules could be detected by microscopy in TZM-bl cells infected with a pseudovirus.  
 
Furthermore, it was a means of establishing that indeed it will work in our setting before 
coupling it to an optical trapping system, which is what the next level of the study would focus 
on. The coupling of an imaging system to our trapping system would enable us to analyze both 
infected and uninfected cells with confidence knowing that the infected cells are marked. Such 
a step would then allow us to carefully study and be able to pick up cellular changes between 
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infected and uninfected cells. As there is a possibility that HIV infection induces changes in 
some cellular molecules and such changes can be used as means of distinguishing between 
infected and uninfected cells. Such a finding would bring a different approach to HIV diagnosis 
as the already established methods focus on antibodies and also on viral molecules. Focusing 
on host molecules will bring in a different approach, which could simplify HIV diagnosis and 
even meet the World Health Organization (WHO) required ASSURED (Affordable, Sensitive, 
Specific, User-friendly, Rapid and robust, Equipment-free and Deliverable to end users) 
standards.  
 
In this thesis laser driven techniques have demonstrated a great potential in the Biophotonics 
research area. The major goal of the work reported here is to develop laser driven point-of-care 
devices for both treatment and diagnosis of various medical conditions. The need to develop 
such devices was motivated by the lack of diagnostic devices and procedures that can be used 
by people in low resource settings. The great improvements in the medical field in recent years 
have brought about an increase in the use of automated laboratory testing procedures with 
reduction in operation time and improvement in reliability. These improvements have been 
beneficial especially because diagnostics have become a vital part of medicine. These systems 
are coupled with the use electronic medical reporting that allows doctors to get results quicker, 
thereby improving patient care [4]. However, such advanced systems cannot be of benefit 
across various population groups. These technologies are centralized and can only be operated 
by highly skilled personnel in specialized facilities. As a result, most laboratory testing is costly 
and unaffordable to the majority of patients particularly in resource limited countries. Due to 
that disparity, various organizations including the WHO proposed the development of different 
diagnostic tools that would be used in situations or locations with poor access to centralized 
laboratories. Such tools can be used at point of care; that is at sites closer to patient care or 
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easily accessible to patients and also provide clinicians with results within hours or minutes [5, 
6 and 7]. These tools eliminate two major steps between sample collection and availability of 
results, which are specimen transportation and laboratory processing. The advent of these tools 
improved health care services for the benefit of the patient. Such devices should meet the 
WHO’s ASSURED criteria as a standard to decide if tests focus on disease control demands: 
Affordable, Sensitive, Specific, User-friendly, Rapid and robust, Equipment-free and 
Deliverable to end users. As such scientists from diverse fields are developing point-of-care 
devices especially for diagnostic purposes [8]. 
 
Finally, the outcomes of chapters 3, 4 and 5 illustrate that light-based label free diagnostic 
techniques are attainable. This is founded on the outcomes of chapters 3 and 4, which show 
that intrinsic properties of cells can be used for diseases diagnosis. For instance, in chapter 3, 
by simply measuring transmittance percentage of HIV infected and uninfected cells it was 
possible to distinguish between the two cell populations. In chapter 4, the capability of TZM-
bl cells to express a luciferase gene when infected by HIV caused them to be differentiated 
from the uninfected ones that do not express the luciferase gene and therefore no luminescence 
can be detected in them. The findings in chapter 5 confirmed what was observed in chapters 3 
and 4. These findings will contribute towards the development of a laser driven HIV point of 
care device that would not only detect the presence of HIV-1 infection, but it will also detect 
the presence of HIV drug resistance mutations as well as viral load detection. 
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Appendices 
Appendix A  
Cell growth conditions, virus production and infection of TZM-bl cells 
I. Conditions for cell growth and maintenance 
The two cells lines that were used are TZM-bl cells (ATCC, PTA-5659) and HEK 293T/17 
cells (ATCC, CRL, 11268). The HEK 293T/17 cell line was used for the production of HIV-1 
pseudovirus that was used to infect TZM-bl cells. Both cell lines were grown, maintained and 
cultured in a cell growth medium made up of Dulbeco’s minimal essential medium (DMEM, 
Sigma-Aldrich, D5796), 10% fetal bovine serum (FBS, FBS Superior, S 0615), 0.5% L-
Glutamine-Penicillin-Streptomycin (Sigma-Aldrich, G6784) at 37°C, 5% CO2 and 85% 
humidity. Since both cell lines were adherent, trypsin-EDTA solution (Sigma-Aldrich, T4049) 
was used to bring cells into suspension as they detach from the surface of the culture flask. The 
cells in suspension were used various experiments. 
 
II. Preparation and titration of ZM53 pseudovirus 
For the production of HIV-1 ZM53 pseudovirus, 4 µg of an expression plasmid containing the 
env gene of ZM53 and 8 µg of a plasmid carrying the backbone of HIV-1, but deficient of the 
env  gene (pSG3ΔEnv) were used to co-transfect HEK 293T/17 cells. The Superfect 
transfection reagent (Qiagen, 310305) was added in the mixture of the two plasmids in order 
to facilitate the entry of DNA into cells with ease due to the interaction between the cell surface 
charges and charges on the Superfect reagent. Using the 50% tissue culture infectious dose 
(TCID50), the suitable virus titre was determined. 
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III. In vitro infection and sample preparation 
For the various assays done, the TZM-bl cells were infected with different volumes (50, 100, 
150 and 200 µl) of the virus in 35 mm diameter culture dishes, with uninfected cells used as a 
negative control and the increase in virus volumes added to cells translates to an increase in 
virus concentration. The infected cells were then incubated for 48 hours in conditions outlined 
in AI. Cells were then rinsed with Hank’s Balance Salt Solution (HBSS) (Gibco, Life 
Technologies, 14170-088), trypsinized, resuspended in growth medium. Following this, cells 
were divided into various parts in order to perform different assays. For imaging experiments, 
the TZM-bl cells were grown on 22 mm2 coverslips in 8 well rectangular culture plates. 
 
Appendix B 
Biological assays 
I. Cell morphology  
The assessment of cell morphology is essential in cell culture experiments, as it is a physical 
means of determining whether the cells are healthy or unhealthy. In this study, cell morphology 
was monitored in order to determine the influence of HIV infection, efavirenz and irradiation 
on the cells. This examination was done using a light microscope (CKX41, Olympus) and 
images were taken using a digital camera attached to the microscope.  
 
II. Cell viability assay 
The CellTiter-Glo® luminescent cell viability assay (Promega, Anatech, G7573) is a means of 
establishing cell viability in culture by quantifying adenosine triphosphate (ATP), which is an 
indicator of metabolically active cells within a given cell population. The addition of the 
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reagent to the cells results in cell lysis, thereby generating a luminescent signal that is 
proportional to the quantity of ATP cells. Equal volumes of cell suspension and ATP reagent 
were added together and mixed to induce cell lysis. The mixture was allowed to stabilize at 
room temperature for 10 minutes in the dark. The luminescence was recorded using the 
GloMax® Discover System (Promega, Anatech) in relative light units (RLUs). 
 
III. Cell proliferation assay 
The CellTiter 96® non-radioactive cell proliferation assay (Anatech, Promega) is a 
colorimetric assay used to evaluate cell metabolic activity. It makes use of NAD(P)H-
dependent cellular oxidoreductase enzymes that reduce the tetrazolium dye MTT 3-(4,5-
dimethylthiazol-2-yl) -2,5-diphenytetrazolium bromide, which is yellow in colour to formazan 
that is purple in colour. The assay was performed in a 96 well plate by mixing 15 μl of the Dye 
solution with 100 μl of the cell suspension and the mixture was then incubated at 37°C for 4 
hours. After 4 of incubation, 100 μl Solubilization solution was added and the plate was 
allowed to stand at room temperature in the dark for 1 hour. Prior to measuring absorbance by 
reading the plate at 600 nm using the Glomax® Discover System, the contents were mixed 
using a multichannel pipette for even distribution of the newly formed substance (formazan). 
 
IV. Membrane integrity assay 
The CytoTox 96® non-radioactive cytotoxicity assay (G1780, Anatech, Promega) is a 
colorimetric assay that measures lactate dehydrogenase (LDH) enzyme. LDH is a stable 
cytosolic enzyme released by damaged tissues and cells into their environment (cell medium). 
This assay therefore evaluates the presence of tissue and cell damage.  
166 
 
It was done by mixing equal volumes of the cell medium and LDH assay reagent in a 96 well 
plate and incubated in the dark at room temperature for 30 minutes. The reaction was 
terminated by adding 50 μl of the Stop solution and absorbance was measured at 490 nm using 
the Glomax® Discover System. 
 
V. Luciferase assay 
A luciferase (Luc) reporter gene assay which measures the reduction of HIV as a function of 
Tat-regulated Luc reporter gene expression after a single round of HIV in TZM-bl cells was 
done using the Bright-Glo™ luciferase assay system (E2610, Anatech, Promega) to evaluate 
HIV infection in TZM-bl cells. TZM-bl cells are a CXCR4 positive cell line that expresses 
both CD4 and CCR5, which are essential cellular surface receptors for the entry of HIV-1 into 
cells. They also contain integrated Tat-inducible luciferase and E.coli β-galactosidase reporter 
genes and these two reporter genes get expressed when TZM-bl cells are infected with HIV. In 
the current study, luciferase activity which is measured by RLUs was determined and RLUs 
are directly proportional to the number of infectious virus particles present in the initial 
inoculum. During the experiment 100 μl of the luciferase reagent was added to an equal volume 
of the cell suspension and incubated in the dark for 2 minutes. The luciferase activity was 
quantified with the GloMax® Discover System. 
 
VI. Flow cytometry 
The flow cytometry experiments using Fluorescein isothiocyanate (FITC) Annexin V 
Apoptosis Detection Kit I (BD Biosciences, Johannesburg, South Africa) were performed to 
determine the type of cell death experienced by cells following HIV infection.  
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Following irradiation at different fluences, the cells were incubated for further 24 hours, 
thereafter flow cytometry experiments were conducted. During flow cytometry experiments, 
the cell culture medium was removed and placed in a 15 ml centrifuge tube. Following this, 
cells in the culture dish were rinsed with HBSS, and 500 μl of trypsin was added in each culture 
dish and placed in the incubator for 5 minutes to allow cells to detach from the culture dish, 
leaving them in suspension. Once successfully in solution, 1 ml of growth medium was added 
to the cells and this mixture transferred to a 15 ml tube containing the culture medium and 
centrifuged for 10 minutes at 2200 rpm. The cell pellet was then rinsed twice with cold PBS 
and re-suspended by adding 500 μl of 1X annexin V binding buffer. From the 500 μl cell 
suspension, 100 μl was stained in 5 ml tubes with 5 μl of annexin-V and 5 μl of propidium 
iodide (PI) and incubated on ice for 30 minutes. The stained cells were suspended in 400 μl of 
annexin V binding buffer before flow cytometric analysis. For positive controls, apoptosis and 
necrosis were induced using Dimethyl sulfoxide (DMSO) and ice cold methanol, respectively. 
The samples were analyzed using the BD Accuri C6 cytometer. 
 
VII. Reactive Oxygen Species Detection  
Reactive Oxygen Species (ROS) was visualized with CellROX® oxidative stress green reagent 
(C10444, Life Technologies), which is a DNA dye that binds with DNA upon oxidation and 
its signal is localized primarily in the nucleus and mitochondria. After irradiation at different 
fluences, the cells were incubated for 1 hour under normal cell growth conditions. After 
incubation, 750 μl of the growth medium was removed and only 250 μl remained in the culture 
dish. To the 250 μl medium, 1 μl of 25 mM CellROX green reagent was added and the contents 
of the dish were mixed by gently swirling to ensure even distribution of the reagent throughout 
the plate and incubated for 30 minutes. The cells were washed three times with 1X Phosphate 
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Buffered Saline (PBS) and 500 μl of PBS was left in the dish to prevent desiccation during 
sample viewing under the fluorescent microscope (CKX41, Olympus).  
 
Appendix C 
Luminescence spectroscopy and imaging experiments 
I. Luminescence Spectroscopy 
The steady state spectra of photoluminescence emission were obtained using a Horiba Jobin 
Yvon Fluorolog 3 photoluminescence spectrometer. For luminescence spectroscopy work, 
equal volumes of the cell suspension and the luciferase agent were mixed and incubated for 2 
minutes before transferring into a plastic cuvette. The cuvette was then transferred into the 
Horiba Jobin Yvon Fluorolog 3 photoluminescence spectrometer system. The emission 
resulting from the expression of the luciferase gene in infected TZM-bl cells was then recorded 
with a fast photomultiplier tube detector coupled to the Horiba Jobin Yvon Fluorolog 3 system.  
 
II. Imaging  
Cells were fixed with 4% formaldhehyde, washed with phosphate buffered saline (PBS) and 
blocked for 10 minutes with 5% donkey serum. Cells were incubated at 4°C with primary 
antibodies (anti-HIV1 p24 antibody and anti-HIV1 gp41 antibody) overnight. The cells were 
washed with PBS before incubating them for an hour with the secondary antibody; donkey 
anti-mouse IgL H&L (Alexa Flour 488) pre-adsorbed (Abcam, ab150109) and washed with 
PBS. For nucleus staining, the cells were incubated with Hoechst for 10 minutes and washed 
with PBS. The coverslips were then mounted on microscope slides using the fluorescence 
mounting media.  
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All samples were visualized and imaged using the Carl Zeiss Confocal LSM 780 Elyra S1 with 
SR-SIM at the Central Analytical Facility, University of Stellenbosch. 
 
